{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T01:18:06Z","timestamp":1787707086995,"version":"build-2784847793"},"reference-count":296,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi del Piemonte Orientale Amedeo Avogrado"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is steadily increasing worldwide, primarily due to the ongoing obesity pandemic. Although MASLD may initially present as a relatively benign condition, it has the potential to progress to metabolic dysfunction-associated steatohepatitis (MASH), a more severe form that can lead to cirrhosis and hepatocellular carcinoma (HCC). A variety of factors contribute to the pathogenesis of MASLD, including gut dysbiosis, insulin resistance, dyslipidemia, lipotoxicity, and oxidative stress. Among these, recent evidence highlights chronic inflammation as a key driver of disease progression toward advanced stages. Global scientific efforts have begun to uncover the molecular mechanisms sustaining the inflammatory response in MASLD, although these pathways remain only partially understood. Furthermore, therapeutic options for MASLD and MASH are currently limited, with no approved pharmacological treatments available for the advanced stages of the disease. This review aims to provide a comprehensive overview of the current understanding of the cellular and molecular mechanisms involved in the inflammatory processes underpinning MASLD and MASH while also outlining the key challenges that lie ahead in the development of effective therapies.<\/jats:p>","DOI":"10.1007\/s10753-026-02545-z","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:46:55Z","timestamp":1781599615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["When the Liver Flares: Inflammatory and Immunometabolic Mechanisms Driving the Transition from MASLD to MASH"],"prefix":"10.1007","volume":"49","author":[{"given":"Cristina","family":"Vecchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anteneh Nigussie","family":"Sheferaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Kivumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Stoppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Pantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Christaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Provera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Dianzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0192-8199","authenticated-orcid":false,"given":"Salvatore","family":"Sutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"Suppl","key":"2545_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M., M. Kalligeros, and L. Henry. 2025. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol 31(Suppl):S32\u2013S50. https:\/\/doi.org\/10.3350\/cmh.2024.0431","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"2545_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","volume":"23","author":"Y Li","year":"2024","unstructured":"Li, Y., P. Yang, J. Ye, Q. Xu, J. Wu, and Y. Wang. 2024. Updated mechanisms of MASLD pathogenesis. Lipids In Health And Disease 23(1):117. https:\/\/doi.org\/10.1186\/s12944-024-02108-x","journal-title":"Lipids In Health And Disease"},{"issue":"2","key":"2545_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4082\/kjfm.25.0027","volume":"46","author":"D Lorek","year":"2025","unstructured":"Lorek, D., K. \u0141upina, W. Bisaga, D. Malicki, W. St\u0119pie\u0144, L. Kumor, and J. Janczura. 2025. The socioeconomic and environmental determinants of metabolic dysfunction-associated steatotic liver disease: understanding inequalities in prevalence and outcomes. Korean J Fam Med 46(2):61\u201369. https:\/\/doi.org\/10.4082\/kjfm.25.0027","journal-title":"Korean J Fam Med"},{"issue":"1","key":"2545_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/HEP.0000000000000329","volume":"78","author":"O Nabi","year":"2023","unstructured":"Nabi, O., N. Lapidus, J. Boursier, V. de Ledinghen, J. M. Petit, S. Kab, A. Renuy, M. Zins, K. Lacombe, and L. Serfaty. 2023. Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study). Hepatology 78(1):272\u2013283. https:\/\/doi.org\/10.1097\/HEP.0000000000000329","journal-title":"Hepatology"},{"issue":"1","key":"2545_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s13679-025-00637-9","volume":"14","author":"C Koliaki","year":"2025","unstructured":"Koliaki, C., M. Dalamaga, K. Kakounis, and S. Liatis. 2025. Metabolically Healthy Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the Controversies in Disease Development and Progression. Curr Obes Rep 14(1):46. https:\/\/doi.org\/10.1007\/s13679-025-00637-9","journal-title":"Curr Obes Rep"},{"key":"2545_CR6","doi-asserted-by":"publisher","first-page":"418185","DOI":"10.1155\/2014\/418185","volume":"2014","author":"L Liu","year":"2014","unstructured":"Liu, L., M. Mei, S. Yang, and Q. Li. 2014. Roles of chronic low-grade inflammation in the development of ectopic fat deposition. Mediators Inflamm 2014:418185. https:\/\/doi.org\/10.1155\/2014\/418185","journal-title":"Mediators Inflamm"},{"issue":"3","key":"2545_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.2040-1124.2011.00111.x","volume":"2","author":"T Matsuzaka","year":"2011","unstructured":"Matsuzaka, T., and H. Shimano. 2011. Molecular mechanisms involved in hepatic steatosis and insulin resistance. J Diabetes Investig 2(3):170\u2013175. https:\/\/doi.org\/10.1111\/j.2040-1124.2011.00111.x","journal-title":"J Diabetes Investig"},{"issue":"3","key":"2545_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13679-022-00473-1","volume":"11","author":"AI Legaki","year":"2022","unstructured":"Legaki, A. I., I. I. Moustakas, M. Sikorska, G. Papadopoulos, R. I. Velliou, and A. Chatzigeorgiou. 2022. Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. Curr Obes Rep 11(3):126\u2013143. https:\/\/doi.org\/10.1007\/s13679-022-00473-1","journal-title":"Curr Obes Rep"},{"issue":"13","key":"2545_CR9","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.3390\/ijms23137280","volume":"23","author":"R Ramanathan","year":"2022","unstructured":"Ramanathan, R., A. H. Ali, and J. A. Ibdah. 2022. Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. International Journal Of Molecular Sciences 23(13):7280. https:\/\/doi.org\/10.3390\/ijms23137280 . PMID: 35806284; PMCID: PMC9267060.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"9","key":"2545_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","volume":"11","author":"P Rada","year":"2020","unstructured":"Rada, P., \u00c1 Gonz\u00e1lez-Rodr\u00edguez, C. Garc\u00eda-Monz\u00f3n, and \u00c1M Valverde. 2020. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death And Disease 11(9):802. https:\/\/doi.org\/10.1038\/s41419-020-03003-w","journal-title":"Cell Death And Disease"},{"issue":"7","key":"2545_CR11","doi-asserted-by":"publisher","first-page":"e186423","DOI":"10.1172\/JCI186423","volume":"135","author":"B Schnabl","year":"2025","unstructured":"Schnabl, B., C. J. Damman, and R. M. Carr. 2025. Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations. J Clin Invest 135(7):e186423. https:\/\/doi.org\/10.1172\/JCI186423","journal-title":"J Clin Invest"},{"issue":"2","key":"2545_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2010.02.032","volume":"53","author":"DG Tiniakos","year":"2010","unstructured":"Tiniakos, D. G., A. Kandilis, and S. A. Geller. 2010. Tityus: a forgotten myth of liver regeneration. Journal Of Hepatology 53(2):357\u2013361. https:\/\/doi.org\/10.1016\/j.jhep.2010.02.032","journal-title":"Journal Of Hepatology"},{"key":"2545_CR13","doi-asserted-by":"publisher","unstructured":"Kisseleva, T., S. Ganguly, R. Murad, A. Wang, and D. A. Brenner. 2025. Regulation of hepatic stellate cell phenotypes in metabolic dysfunction-associated steatohepatitis. Gastroenterology 20:S0016-5085(25)00528-1. https:\/\/doi.org\/10.1053\/j.gastro.2025.03.010","DOI":"10.1053\/j.gastro.2025.03.010"},{"issue":"6","key":"2545_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/cells14060428","volume":"14","author":"T Nakamura","year":"2025","unstructured":"Nakamura, T., A. Masuda, D. Nakano, K. Amano, T. Sano, M. Nakano, and T. Kawaguchi. 2025. Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma. Cells 14(6):428. https:\/\/doi.org\/10.3390\/cells14060428. PMID: 40136677; PMCID: PMC11941585.","journal-title":"Cells"},{"issue":"7","key":"2545_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee, Q. M., H. L. Reeves, E. Kotsiliti, O. Govaere, and M. Heikenwalder. 2019. From NASH to HCC: current concepts and future challenges. Nature Reviews. Gastroenterology & Hepatology 16(7):411\u2013428. https:\/\/doi.org\/10.1038\/s41575-019-0145-7","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"4","key":"2545_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/jpm14040370","volume":"14","author":"C Leyh","year":"2024","unstructured":"Leyh, C., J. D. Coombes, H. H. Schmidt, A. Canbay, P. P. Manka, and J. Best. 2024. MASLD-Related HCC-Update on Pathogenesis and Current Treatment Options. J Pers Med 14(4):370. https:\/\/doi.org\/10.3390\/jpm14040370","journal-title":"J Pers Med"},{"issue":"3","key":"2545_CR17","doi-asserted-by":"publisher","first-page":"101271","DOI":"10.1016\/j.jhepr.2024.101271","volume":"7","author":"G Feng","year":"2024","unstructured":"Feng, G., G. Targher, C. D. Byrne, Y. Yilmaz, V. Wai-Sun Wong, C. R. Adithya Lesmana, L. A. Adams, J. Boursier, G. Papatheodoridis, M. El-Kassas, N. M\u00e9ndez-S\u00e1nchez, S. Sookoian, L. Castera, W. K. Chan, F. Ye, S. Treeprasertsuk, H. Cortez-Pinto, H. H. Yu, W. Kim, M. Romero-G\u00f3mez, A. Nakajima, K. M. Win, S. U. Kim, A. G. Holleboom, G. Sebastiani, P. Ocama, J. D. Ryan, M. Lup\u0219or-Platon, H. Ghazinyan, M. Al-Mahtab, S. Hamid, N. Perera, K. A. Alswat, Q. Pan, M. T. Long, V. Isakov, M. Mi, M. Arrese, A. J. Sanyal, S. K. Sarin, N. C. Leite, L. Valenti, P. N. Newsome, H. Hagstr\u00f6m, S. Petta, H. Yki-J\u00e4rvinen, J. M. Schattenberg, M. I. Castellanos Fern\u00e1ndez, I. A. Leclercq, G. Aghayeva, A. N. Elzouki, A. Tumi, A. I. Sharara, A. Labidi, F. M. Sanai, K. Matar, M. Al-Mattooq, M. W. Akroush, M. Benazzouz, N. Debzi, M. Alkhatry, S. Barakat, S. A. Al-Busafi, J. Rwegasha, W. Yang, A. Adwoa, C. K. Opio, M. Sotoudeheian, Y. J. Wong, J. George, and M. H. Zheng. 2024. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. JHEP Rep 7(3):101271. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101271","journal-title":"JHEP Rep"},{"issue":"2","key":"2545_CR18","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.pharmr.2024.100018","volume":"77","author":"X Zhang","year":"2025","unstructured":"Zhang, X., H. C. Lau, and J. Yu. 2025. Pharmacological treatment for metabolic dysfunction-associated steatotic liver disease and related disorders: Current and emerging therapeutic options. Pharmacological Reviews 77(2):100018. https:\/\/doi.org\/10.1016\/j.pharmr.2024.100018","journal-title":"Pharmacological Reviews"},{"issue":"7540","key":"2545_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature13989","volume":"518","author":"E Gomez Perdiguero","year":"2015","unstructured":"Gomez Perdiguero, E., K. Klapproth, C. Schulz, K. Busch, E. Azzoni, L. Crozet, H. Garner, C. Trouillet, M. F. de Bruijn, F. Geissmann, and H. R. Rodewald. 2015. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518(7540):547\u2013551. https:\/\/doi.org\/10.1038\/nature13989","journal-title":"Nature"},{"key":"2545_CR20","doi-asserted-by":"publisher","first-page":"940867","DOI":"10.3389\/fimmu.2022.940867","volume":"13","author":"W Li","year":"2022","unstructured":"Li, W., N. Chang, and L. Li. 2022. Heterogeneity and Function of Kupffer Cells in Liver Injury. Frontiers In Immunology 13:940867. https:\/\/doi.org\/10.3389\/fimmu.2022.940867","journal-title":"Frontiers In Immunology"},{"key":"2545_CR21","doi-asserted-by":"publisher","first-page":"119513","DOI":"10.1016\/j.ecoenv.2025.119513","volume":"309","author":"H Chen","year":"2026","unstructured":"Chen, H., H. Cui, and Z. Meng. 2026. The nexus of environmental endocrine-disrupting chemical exposure and metabolic dysfunction-associated steatotic liver disease: An emerging public health challenge. Ecotoxicology And Environmental Safety 309:119513. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.119513","journal-title":"Ecotoxicology And Environmental Safety"},{"issue":"12","key":"2545_CR22","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1007\/s12011-023-03629-9","volume":"201","author":"P Sadighara","year":"2023","unstructured":"Sadighara, P., A. H. Abedini, N. Irshad, M. Ghazi-Khansari, A. Esrafili, and M. Yousefi. 2023. Association Between Non-alcoholic Fatty Liver Disease and Heavy Metal Exposure: a Systematic Review. Biological Trace Element Research 201(12):5607\u20135615. https:\/\/doi.org\/10.1007\/s12011-023-03629-9. Epub 2023 Mar 16. PMID: 36929113.","journal-title":"Biological Trace Element Research"},{"key":"2545_CR23","doi-asserted-by":"publisher","first-page":"1512901","DOI":"10.3389\/fpubh.2024.1512901","volume":"12","author":"H Ma","year":"2025","unstructured":"Ma, H., J. Zhao, and J. Xu. 2025. The correlation between heavy metal ions in blood and metabolic dysfunction-associated steatotic liver disease from 1999 to 2018 based on NHANES data. Front Public Health 12:1512901. https:\/\/doi.org\/10.3389\/fpubh.2024.1512901. PMID: 39839416; PMCID: PMC11747274.","journal-title":"Front Public Health"},{"issue":"20","key":"2545_CR24","doi-asserted-by":"publisher","first-page":"12213","DOI":"10.3390\/ijms232012213","volume":"23","author":"R Teschke","year":"2022","unstructured":"Teschke, R., and Aluminum. 2022. Arsenic, Beryllium, Cadmium, Chromium, Cobalt, Copper, Iron, Lead, Mercury, Molybdenum, Nickel, Platinum, Thallium, Titanium, Vanadium, and Zinc: Molecular Aspects in Experimental Liver Injury. International Journal Of Molecular Sciences 23(20):12213. https:\/\/doi.org\/10.3390\/ijms232012213. PMID: 36293069; PMCID: PMC9602583.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"4","key":"2545_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jhep.2020.04.033","volume":"73","author":"H Han","year":"2020","unstructured":"Han, H., R. Desert, S. Das, Z. Song, D. Athavale, X. Ge, and N. Nieto. 2020. Danger signals in liver injury and restoration of homeostasis. Journal Of Hepatology 73(4):933\u2013951. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.033","journal-title":"Journal Of Hepatology"},{"issue":"1","key":"2545_CR26","first-page":"101","volume":"1","author":"AT Nguyen-Lefebvre","year":"2015","unstructured":"Nguyen-Lefebvre, A. T., and A. Horuzsko. 2015. Kupffer Cell Metabolism and Function. J Enzymol Metab 1(1):101. Epub 2015 Aug 14.","journal-title":"J Enzymol Metab"},{"issue":"6","key":"2545_CR27","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","volume":"15","author":"J Vonderlin","year":"2023","unstructured":"Vonderlin, J., T. Chavakis, M. Sieweke, and F. Tacke. 2023. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis. Cell Mol Gastroenterol Hepatol 15(6):1311\u20131324. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.03.002","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"2545_CR28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s42003-024-06357-5","volume":"7","author":"A Iwata","year":"2024","unstructured":"Iwata, A., J. Maruyama, S. Natsuki, A. Nishiyama, T. Tamura, M. Tanaka, S. Shichino, T. Seki, T. Komai, T. Okamura, K. Fujio, M. Tanaka, and K. Asano. 2024. Egr2 drives the differentiation of Ly6Chi monocytes into fibrosis-promoting macrophages in metabolic dysfunction-associated steatohepatitis in mice. Commun Biol 7(1):681. https:\/\/doi.org\/10.1038\/s42003-024-06357-5","journal-title":"Commun Biol"},{"issue":"11","key":"2545_CR29","doi-asserted-by":"publisher","first-page":"101196","DOI":"10.1016\/j.jhepr.2024.101196","volume":"6","author":"FF De Ponti","year":"2024","unstructured":"De Ponti, F. F., Z. Liu, and C. L. Scott. 2024. Understanding the complex macrophage landscape in MASLD. JHEP Rep 6(11):101196. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101196","journal-title":"JHEP Rep"},{"issue":"1","key":"2545_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12964-025-02222-y","volume":"23","author":"M Vahrenbrink","year":"2025","unstructured":"Vahrenbrink, M., C. D. Coleman, S. Kuipers, I. Lurje, L. Hammerich, D. Kunkel, J. Keye, S. Dittrich, B. M. Schjeide, R. Hi\u00df, J. M\u00fcller, G. P. P\u00fcschel, and J. Henkel. 2025. Dynamic changes in macrophage populations and resulting alterations in Prostaglandin E2 sensitivity in mice with diet-induced MASH. Cell Commun Signal 23(1):227. https:\/\/doi.org\/10.1186\/s12964-025-02222-y","journal-title":"Cell Commun Signal"},{"issue":"2","key":"2545_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/hep.27141","volume":"60","author":"I Locatelli","year":"2014","unstructured":"Locatelli, I., S. Sutti, A. Jindal, M. Vacchiano, C. Bozzola, C. Reutelingsperger, D. Kusters, S. Bena, M. Parola, C. Paternostro, E. Bugianesi, S. McArthur, E. Albano, and M. Perretti. 2014. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. Hepatology 60(2):531\u2013544. https:\/\/doi.org\/10.1002\/hep.27141","journal-title":"Hepatology"},{"key":"2545_CR32","doi-asserted-by":"publisher","first-page":"1257596","DOI":"10.3389\/fimmu.2023.1257596","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang, W., and R. Lang. 2023. Macrophage metabolism in nonalcoholic fatty liver disease. Frontiers In Immunology 14:1257596. https:\/\/doi.org\/10.3389\/fimmu.2023.1257596","journal-title":"Frontiers In Immunology"},{"issue":"2","key":"2545_CR33","doi-asserted-by":"publisher","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","volume":"34","author":"S Daemen","year":"2021","unstructured":"Daemen, S., A. Gainullina, G. Kalugotla, L. He, M. M. Chan, J. W. Beals, K. H. Liss, S. Klein, A. E. Feldstein, B. N. Finck, M. N. Artyomov, and J. D. Schilling. 2021. Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH. Cell Rep 34(2):108626. https:\/\/doi.org\/10.1016\/j.celrep.2020.108626","journal-title":"Cell Rep"},{"issue":"2","key":"2545_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4254\/wjh.v15.i2.201","volume":"15","author":"M Kram","year":"2023","unstructured":"Kram, M. 2023. Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis. World Journal Of Hepatology 15(2):201\u2013207. https:\/\/doi.org\/10.4254\/wjh.v15.i2.201","journal-title":"World Journal Of Hepatology"},{"key":"2545_CR35","doi-asserted-by":"publisher","first-page":"8162421","DOI":"10.1155\/2017\/8162421","volume":"2017","author":"A Alisi","year":"2017","unstructured":"Alisi, A., G. Carpino, F. L. Oliveira, N. Panera, V. Nobili, and E. Gaudio. 2017. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. Mediators Inflamm 2017:8162421. https:\/\/doi.org\/10.1155\/2017\/8162421","journal-title":"Mediators Inflamm"},{"issue":"5","key":"2545_CR36","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.7150\/thno.106597","volume":"15","author":"M Yan","year":"2025","unstructured":"Yan, M., Y. Cui, and Q. Xiang. 2025. Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions. Theranostics 15(5):1715\u20131740. https:\/\/doi.org\/10.7150\/thno.106597","journal-title":"Theranostics"},{"issue":"1","key":"2545_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/cells9010028","volume":"9","author":"B Foglia","year":"2019","unstructured":"Foglia, B., S. Sutti, D. Pedicini, S. Cannito, C. Bocca, M. Maggiora, M. R. Bevacqua, C. Rosso, E. Bugianesi, E. Albano, E. Novo, M. Parola, and M. Oncostatin. 2019. A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts. Cells 9(1):28. https:\/\/doi.org\/10.3390\/cells9010028","journal-title":"Cells"},{"issue":"10","key":"2545_CR38","doi-asserted-by":"publisher","first-page":"113164","DOI":"10.1016\/j.celrep.2023.113164","volume":"42","author":"W Li","year":"2023","unstructured":"Li, W., Y. Yang, L. Yang, N. Chang, and L. Li. 2023. Monocyte-derived Kupffer cells dominate in the Kupffer cell pool during liver injury. Cell Rep 42(10):113164. https:\/\/doi.org\/10.1016\/j.celrep.2023.113164","journal-title":"Cell Rep"},{"key":"2545_CR39","doi-asserted-by":"publisher","first-page":"1569915","DOI":"10.3389\/fimmu.2025.1569915","volume":"16","author":"Q Wu","year":"2025","unstructured":"Wu, Q., Y. Yang, S. Lin, D. A. Geller, and Y. Yan. 2025. The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC. Frontiers In Immunology 16:1569915. https:\/\/doi.org\/10.3389\/fimmu.2025.1569915","journal-title":"Frontiers In Immunology"},{"issue":"1","key":"2545_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T Csak","year":"2011","unstructured":"Csak, T., M. Ganz, J. Pespisa, K. Kodys, A. Dolganiuc, and G. Szabo. 2011. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54(1):133\u2013144. https:\/\/doi.org\/10.1002\/hep.24341","journal-title":"Hepatology"},{"issue":"1","key":"2545_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jhep.2024.06.040","volume":"82","author":"Y Kwon","year":"2025","unstructured":"Kwon, Y., P. Gottmann, S. Wang, J. Tissink, K. Motzler, R. Sekar, W. Albrecht, C. Cadenas, J. G. Hengstler, A. Sch\u00fcrmann, and A. Zeigerer. 2025. Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease. Journal Of Hepatology 82(1):18\u201327. https:\/\/doi.org\/10.1016\/j.jhep.2024.06.040","journal-title":"Journal Of Hepatology"},{"issue":"17","key":"2545_CR42","doi-asserted-by":"publisher","first-page":"9591","DOI":"10.3390\/ijms25179591","volume":"25","author":"VM Arruda","year":"2024","unstructured":"Arruda, V. M., G. T. Azevedo, M. J. M. G. Granato, A. C. P. Matos, T. G. Ara\u00fajo, and J. F. D. C. Guerra. 2024. Oxidative Stress and Annexin A2 Differential Expression in Free Fatty Acids-Induced Non-Alcoholic Fatty Liver Disease in HepG2 Cells. International Journal Of Molecular Sciences 25(17):9591. https:\/\/doi.org\/10.3390\/ijms25179591","journal-title":"International Journal Of Molecular Sciences"},{"issue":"5","key":"2545_CR43","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/jhep.2003.50191","volume":"37","author":"J Herkel","year":"2003","unstructured":"Herkel, J., B. Jagemann, C. Wiegard, J. F. Lazaro, S. Lueth, S. Kanzler, M. Blessing, E. Schmitt, and A. W. Lohse. 2003. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes. Hepatology 37(5):1079\u20131085. https:\/\/doi.org\/10.1053\/jhep.2003.50191","journal-title":"Hepatology"},{"key":"2545_CR44","doi-asserted-by":"publisher","unstructured":"Franco, A., V. Barnaba, P. Natali, C. Balsano, A. Musca, and F. Balsano. 1988. Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 8(3):449\u2013454. https:\/\/doi.org\/10.1002\/hep.1840080302","DOI":"10.1002\/hep.1840080302"},{"issue":"3","key":"2545_CR45","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jhep.2006.04.008","volume":"45","author":"A Suzuki","year":"2006","unstructured":"Suzuki, A., S. McCall, S. S. Choi, J. K. Sicklick, J. Huang, Y. Qi, M. Zdanowicz, T. Camp, Y. X. Li, and A. M. Diehl. 2006. Interleukin-15 increases hepatic regenerative activity. Journal Of Hepatology 45(3):410\u2013418. https:\/\/doi.org\/10.1016\/j.jhep.2006.04.008","journal-title":"Journal Of Hepatology"},{"issue":"7854","key":"2545_CR46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"M Dudek","year":"2021","unstructured":"Dudek, M., D. Pfister, S. Donakonda, P. Filpe, A. Schneider, M. Laschinger, D. Hartmann, N. H\u00fcser, P. Meiser, F. Bayerl, D. Inverso, J. Wigger, M. Sebode, R. \u00d6llinger, R. Rad, S. Hegenbarth, M. Anton, A. Guillot, A. Bowman, D. Heide, F. M\u00fcller, P. Ramadori, V. Leone, C. Garcia-Caceres, T. Gruber, G. Seifert, A. M. Kabat, J. P. Mallm, S. Reider, M. Effenberger, S. Roth, A. T. Billeter, B. M\u00fcller-Stich, E. J. Pearce, F. Koch-Nolte, R. K\u00e4ser, H. Tilg, R. Thimme, T. Boettler, F. Tacke, J. F. Dufour, D. Haller, P. J. Murray, R. Heeren, D. Zehn, J. P. B\u00f6ttcher, M. Heikenw\u00e4lder, and P. A. Knolle. 2021. Auto-aggressive CXCR6\u2009+\u2009CD8 T cells cause liver immune pathology in NASH. Nature 592(7854):444\u2013449. https:\/\/doi.org\/10.1038\/s41586-021-03233-8","journal-title":"Nature"},{"issue":"5","key":"2545_CR47","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.191.5.771","volume":"191","author":"MK Kennedy","year":"2000","unstructured":"Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, K. Brasel, P. J. Morrissey, K. Stocking, J. C. Schuh, S. Joyce, and J. J. Peschon. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. Journal Of Experimental Medicine 191(5):771\u2013780. https:\/\/doi.org\/10.1084\/jem.191.5.771","journal-title":"Journal Of Experimental Medicine"},{"key":"2545_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cyto.2016.01.020","volume":"82","author":"Y Cepero-Donates","year":"2016","unstructured":"Cepero-Donates, Y., G. Lacraz, F. Ghobadi, V. Rakotoarivelo, S. Orkhis, M. Mayhue, Y. G. Chen, M. Rola-Pleszczynski, A. Menendez, S. Ilangumaran, and S. Ramanathan. 2016. Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease. Cytokine 82:102\u2013111. https:\/\/doi.org\/10.1016\/j.cyto.2016.01.020","journal-title":"Cytokine"},{"issue":"47","key":"2545_CR49","doi-asserted-by":"publisher","first-page":"e2405678","DOI":"10.1002\/advs.202405678","volume":"11","author":"S Wang","year":"2024","unstructured":"Wang, S., J. Gao, M. Yang, G. Zhang, L. Yin, and X. Tong. 2024. OPN-Mediated Crosstalk Between Hepatocyte E4BP4 and Hepatic Stellate Cells Promotes MASH-Associated Liver Fibrosis. Adv Sci (Weinh) 11(47):e2405678. https:\/\/doi.org\/10.1002\/advs.202405678","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2545_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/path.5871","volume":"257","author":"G Di Maira","year":"2022","unstructured":"Di Maira, G., B. Foglia, L. Napione, C. Turato, M. Maggiora, S. Sutti, E. Novo, M. Alvaro, R. Autelli, S. Colombatto, F. Bussolino, P. Carucci, S. Gaia, C. Rosso, A. Biasiolo, P. Pontisso, E. Bugianesi, E. Albano, F. Marra, M. Parola, and S. Cannito. 2022. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis. The Journal Of Pathology 257(1):82\u201395. https:\/\/doi.org\/10.1002\/path.5871","journal-title":"The Journal Of Pathology"},{"issue":"1","key":"2545_CR51","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1038\/s41598-017-03744-3","volume":"7","author":"E Novo","year":"2017","unstructured":"Novo, E., G. Villano, C. Turato, S. Cannito, C. Paternostro, C. Busletta, A. Biasiolo, S. Quarta, E. Morello, C. Bocca, A. Miglietta, E. David, S. Sutti, M. Plebani, E. Albano, M. Parola, and P. Pontisso. 2017. SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells. Scientific Reports 7(1):3420. https:\/\/doi.org\/10.1038\/s41598-017-03744-3","journal-title":"Scientific Reports"},{"key":"2545_CR52","doi-asserted-by":"publisher","first-page":"910526","DOI":"10.3389\/fimmu.2022.910526","volume":"13","author":"E Novo","year":"2022","unstructured":"Novo, E., A. Cappon, G. Villano, S. Quarta, S. Cannito, C. Bocca, C. Turato, M. Guido, M. Maggiora, F. Protopapa, S. Sutti, A. Provera, M. Ruvoletto, A. Biasiolo, B. Foglia, E. Albano, P. Pontisso, and M. Parola. 2022. SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease. Frontiers In Immunology 13:910526. https:\/\/doi.org\/10.3389\/fimmu.2022.910526","journal-title":"Frontiers In Immunology"},{"issue":"6","key":"2545_CR53","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/hep.29754","volume":"67","author":"E Morello","year":"2018","unstructured":"Morello, E., S. Sutti, B. Foglia, E. Novo, S. Cannito, C. Bocca, M. Rajsky, S. Bruzz\u00ec, M. L. Abate, C. Rosso, C. Bozzola, E. David, E. Bugianesi, E. Albano, and M. Parola. 2018. Hypoxia-inducible factor 2\u03b1 drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein. Hepatology 67(6):2196\u20132214. https:\/\/doi.org\/10.1002\/hep.29754","journal-title":"Hepatology"},{"key":"2545_CR54","doi-asserted-by":"publisher","first-page":"1342404","DOI":"10.3389\/fimmu.2024.1342404","volume":"15","author":"B Foglia","year":"2024","unstructured":"Foglia, B., S. Sutti, S. Cannito, C. Rosso, M. Maggiora, A. Casalino, C. Bocca, E. Novo, F. Protopapa, N. N. Ramavath, A. Provera, A. Gambella, E. Bugianesi, F. Tacke, E. Albano, and M. Parola. 2024. Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis. Frontiers In Immunology 15:1342404. https:\/\/doi.org\/10.3389\/fimmu.2024.1342404","journal-title":"Frontiers In Immunology"},{"key":"2545_CR55","doi-asserted-by":"publisher","unstructured":"Cannito, S., B. Foglia, G. Villano, C. Turato, T. C. Delgado, E. Morello, F. Pin, E. Novo, L. Napione, S. Quarta, M. Ruvoletto, S. Fasolato, G. Zanus, S. Colombatto, F. Lopitz-Otsoa, D. Fern\u00e1ndez-Ramos, F. Bussolino, S. Sutti, E. Albano, M. L. Mart\u00ednez-Chantar, P. Pontisso, and M. Parola. 2019. SerpinB3 differently up-regulates hypoxia inducible factors \u2013\u20091\u03b1 and \u2013\u20092\u03b1 in hepatocellular carcinoma: mechanisms revealing novel potential therapeutic targets. Cancers (Basel) 11(12):1933. https:\/\/doi.org\/10.3390\/cancers11121933","DOI":"10.3390\/cancers11121933"},{"issue":"5","key":"2545_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","volume":"16","author":"JM Banales","year":"2019","unstructured":"Banales, J. M., R. C. Huebert, T. Karlsen, M. Strazzabosco, N. F. LaRusso, and G. J. Gores. 2019. Cholangiocyte pathobiology. Nature Reviews. Gastroenterology & Hepatology 16(5):269\u2013281. https:\/\/doi.org\/10.1038\/s41575-019-0125-y","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"11","key":"2545_CR57","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.4049\/jimmunol.175.11.7447","volume":"175","author":"XM Chen","year":"2005","unstructured":"Chen, X. M., S. P. O\u2019Hara, J. B. Nelson, P. L. Splinter, A. J. Small, P. S. Tietz, A. H. Limper, and N. F. LaRusso. 2005. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. The Journal Of Immunology 175(11):7447\u20137456. https:\/\/doi.org\/10.4049\/jimmunol.175.11.7447","journal-title":"The Journal Of Immunology"},{"issue":"2","key":"2545_CR58","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.4049\/jimmunol.174.2.1055","volume":"174","author":"M Heydtmann","year":"2005","unstructured":"Heydtmann, M., P. F. Lalor, J. A. Eksteen, S. G. H\u00fcbscher, M. Briskin, and D. H. Adams. 2005. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. The Journal Of Immunology 174(2):1055\u20131062. https:\/\/doi.org\/10.4049\/jimmunol.174.2.1055","journal-title":"The Journal Of Immunology"},{"issue":"4 Pt B","key":"2545_CR59","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.bbadis.2017.07.024","volume":"1864","author":"C Pinto","year":"2018","unstructured":"Pinto, C., D. M. Giordano, L. Maroni, and M. Marzioni. 2018. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology. Biochim Biophys Acta Mol Basis Dis 1864(4 Pt B):1270\u20131278. https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"19","key":"2545_CR60","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3748\/wjg.v28.i19.2088","volume":"28","author":"Y Chen","year":"2022","unstructured":"Chen, Y., W. K. Gao, Y. Y. Shu, and J. Ye. 2022. Mechanisms of ductular reaction in non-alcoholic steatohepatitis. World Journal Of Gastroenterology 28(19):2088\u20132099. https:\/\/doi.org\/10.3748\/wjg.v28.i19.2088","journal-title":"World Journal Of Gastroenterology"},{"key":"2545_CR61","doi-asserted-by":"publisher","unstructured":"Chen, X. M., S. P. O\u2019Hara, and N. F. LaRusso. 2008. The immunobiology of cholangiocytes. Immunology & Cell Biology 86(6):497\u2013505. https:\/\/doi.org\/10.1038\/icb.2008.37","DOI":"10.1038\/icb.2008.37"},{"issue":"1","key":"2545_CR62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13287-024-03852-8","volume":"15","author":"I Wilhelmsen","year":"2024","unstructured":"Wilhelmsen, I., T. Combriat, A. Dalmao-Fernandez, J. Stokowiec, C. Wang, P. A. Olsen, J. A. Wik, Y. Boichuk, A. Aizenshtadt, and S. Krauss. 2024. The effects of TGF-\u03b2-induced activation and starvation of vitamin A and palmitic acid on human stem cell-derived hepatic stellate cells. Stem Cell Research & Therapy 15(1):223. https:\/\/doi.org\/10.1186\/s13287-024-03852-8","journal-title":"Stem Cell Research & Therapy"},{"issue":"6","key":"2545_CR63","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/s0168-8278(99)80327-4","volume":"31","author":"F Marra","year":"1999","unstructured":"Marra, F. 1999. Hepatic stellate cells and the regulation of liver inflammation. Journal Of Hepatology 31(6):1120\u20131130. https:\/\/doi.org\/10.1016\/s0168-8278(99)80327-4","journal-title":"Journal Of Hepatology"},{"key":"2545_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-016-0005-6","volume":"36","author":"T Fujita","year":"2016","unstructured":"Fujita, T., and S. Narumiya. 2016. Roles of hepatic stellate cells in liver inflammation: a new perspective. Inflamm Regen 36:1. https:\/\/doi.org\/10.1186\/s41232-016-0005-6","journal-title":"Inflamm Regen"},{"issue":"6","key":"2545_CR65","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3978\/j.issn.2304-3881.2014.11.03","volume":"3","author":"R Weiskirchen","year":"2014","unstructured":"Weiskirchen, R., and F. Tacke. 2014. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr 3(6):344\u2013363. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2014.11.03","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"2","key":"2545_CR66","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/hep.30252","volume":"69","author":"ME Inzaugarat","year":"2019","unstructured":"Inzaugarat, M. E., C. D. Johnson, T. M. Holtmann, M. D. McGeough, C. Trautwein, B. G. Papouchado, R. Schwabe, H. M. Hoffman, A. Wree, and A. E. Feldstein. 2019. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice. Hepatology 69(2):845\u2013859. https:\/\/doi.org\/10.1002\/hep.30252","journal-title":"Hepatology"},{"issue":"1","key":"2545_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. 2008. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiological Reviews 88(1):125\u2013172. https:\/\/doi.org\/10.1152\/physrev.00013.2007","journal-title":"Physiological Reviews"},{"issue":"1","key":"2545_CR68","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/jleuko\/qiae053","volume":"116","author":"J Hagenstein","year":"2024","unstructured":"Hagenstein, J., S. Burkhardt, P. Sprezyna, E. Tasika, G. Tiegs, and L. Diehl. 2024. CD44 expression on murine hepatic stellate cells promotes the induction of monocytic and polymorphonuclear myeloid-derived suppressor cells. Journal Of Leukocyte Biology 116(1):177\u2013185. https:\/\/doi.org\/10.1093\/jleuko\/qiae053","journal-title":"Journal Of Leukocyte Biology"},{"issue":"9","key":"2545_CR69","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam, A., S. Mohammadian, H. Vazini, M. Taghadosi, S. A. Esmaeili, F. Mardani, B. Seifi, A. Mohammadi, J. T. Afshari, and A. Sahebkar. 2018. Macrophage plasticity, polarization, and function in health and disease. Journal Of Cellular Physiology 233(9):6425\u20136440. https:\/\/doi.org\/10.1002\/jcp.26429","journal-title":"Journal Of Cellular Physiology"},{"issue":"1","key":"2545_CR70","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","volume":"66","author":"J Poisson","year":"2017","unstructured":"Poisson, J., S. Lemoinne, C. Boulanger, F. Durand, R. Moreau, D. Valla, and P. E. Rautou. 2017. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. Journal Of Hepatology 66(1):212\u2013227. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.009","journal-title":"Journal Of Hepatology"},{"issue":"2","key":"2545_CR71","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","volume":"78","author":"MJ McConnell","year":"2023","unstructured":"McConnell, M. J., E. Kostallari, S. H. Ibrahim, and Y. Iwakiri. 2023. The evolving role of liver sinusoidal endothelial cells in liver health and disease. Hepatology 78(2):649\u2013669. https:\/\/doi.org\/10.1097\/HEP.0000000000000207","journal-title":"Hepatology"},{"issue":"3","key":"2545_CR72","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3350\/cmh.2024.0022","volume":"30","author":"J Qu","year":"2024","unstructured":"Qu, J., L. Wang, Y. Li, and X. Li. 2024. Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis. Clin Mol Hepatol 30(3):303\u2013325. https:\/\/doi.org\/10.3350\/cmh.2024.0022. Epub 2024 Feb 28.","journal-title":"Clin Mol Hepatol"},{"issue":"11","key":"2545_CR73","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1172\/JCI119842","volume":"100","author":"V Shah","year":"1997","unstructured":"Shah, V., F. G. Haddad, G. Garcia-Cardena, J. A. Frangos, A. Mennone, R. J. Groszmann, and W. C. Sessa. 1997. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 100(11):2923\u20132930. https:\/\/doi.org\/10.1172\/JCI119842","journal-title":"J Clin Invest"},{"issue":"1","key":"2545_CR74","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/hep.510240137","volume":"24","author":"DC Rockey","year":"1996","unstructured":"Rockey, D. C., and R. A. Weisiger. 1996. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 24(1):233\u2013240. https:\/\/doi.org\/10.1002\/hep.510240137","journal-title":"Hepatology"},{"issue":"2","key":"2545_CR75","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cld.2013.12.001","volume":"18","author":"Y Iwakiri","year":"2014","unstructured":"Iwakiri, Y. 2014. Pathophysiology of portal hypertension. Clinics In Liver Disease 18(2):281\u2013291. https:\/\/doi.org\/10.1016\/j.cld.2013.12.001","journal-title":"Clinics In Liver Disease"},{"issue":"12","key":"2545_CR76","doi-asserted-by":"publisher","first-page":"R1217","DOI":"10.1152\/ajpregu.00686.2011","volume":"303","author":"KK S\u00f8rensen","year":"2012","unstructured":"S\u00f8rensen, K. K., P. McCourt, T. Berg, C. Crossley, D. Le Couteur, K. Wake, and B. Smedsr\u00f8d. 2012. The scavenger endothelial cell: a new player in homeostasis and immunity. American Journal Of Physiology: Regulatory, Integrative And Comparative Physiology 303(12):R1217\u2013R1230. https:\/\/doi.org\/10.1152\/ajpregu.00686.2011","journal-title":"American Journal Of Physiology: Regulatory, Integrative And Comparative Physiology"},{"issue":"1\u20132","key":"2545_CR77","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.molimm.2011.09.003","volume":"49","author":"CY Zhang","year":"2011","unstructured":"Zhang, C. Y., and J. W. Booth. 2011. Differences in endocytosis mediated by Fc\u03b3RIIA and Fc\u03b3RIIB2. Molecular Immunology 49(1\u20132):329\u2013337. https:\/\/doi.org\/10.1016\/j.molimm.2011.09.003","journal-title":"Molecular Immunology"},{"issue":"6","key":"2545_CR78","doi-asserted-by":"publisher","first-page":"e143690","DOI":"10.1172\/JCI143690","volume":"131","author":"K Furuta","year":"2021","unstructured":"Furuta, K., Q. Guo, K. D. Pavelko, J. H. Lee, K. D. Robertson, Y. Nakao, J. Melek, V. H. Shah, P. Hirsova, and S. H. Ibrahim. 2021. Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis. J Clin Invest 131(6):e143690. https:\/\/doi.org\/10.1172\/JCI143690","journal-title":"J Clin Invest"},{"issue":"1","key":"2545_CR79","doi-asserted-by":"publisher","first-page":"G67","DOI":"10.1152\/ajpgi.00009.2021","volume":"321","author":"SH Ibrahim","year":"2021","unstructured":"Ibrahim, S. H. 2021. Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications. American Journal Of Physiology. Gastrointestinal And Liver Physiology 321(1):G67\u2013G74. https:\/\/doi.org\/10.1152\/ajpgi.00009.2021","journal-title":"American Journal Of Physiology. Gastrointestinal And Liver Physiology"},{"issue":"11","key":"2545_CR80","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/biology9110395","volume":"9","author":"K Furuta","year":"2020","unstructured":"Furuta, K., Q. Guo, P. Hirsova, and S. H. Ibrahim. 2020. Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic Steatohepatitis. Biology (Basel) 9(11):395. https:\/\/doi.org\/10.3390\/biology9110395","journal-title":"Biology (Basel)"},{"issue":"8","key":"2545_CR81","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3748\/wjg.v18.i8.727","volume":"18","author":"V Braunersreuther","year":"2012","unstructured":"Braunersreuther, V., G. L. Viviani, F. Mach, and F. Montecucco. 2012. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World Journal Of Gastroenterology 18(8):727\u2013735. https:\/\/doi.org\/10.3748\/wjg.v18.i8.727","journal-title":"World Journal Of Gastroenterology"},{"issue":"6","key":"2545_CR82","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster, S., D. Cabrera, M. Arrese, and A. E. Feldstein. 2018. Triggering and resolution of inflammation in NASH. Nature Reviews. Gastroenterology & Hepatology 15(6):349\u2013364. https:\/\/doi.org\/10.1038\/s41575-018-0009-6","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"5","key":"2545_CR83","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha, A. R., A. Wree, A. A. B. Robertson, M. M. Yeh, C. D. Johnson, D. M. Van Rooyen, F. Haczeyni, N. C. Teoh, C. Savard, G. N. Ioannou, S. L. Masters, K. Schroder, M. A. Cooper, A. E. Feldstein, and G. C. Farrell. 2017. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Journal Of Hepatology 66(5):1037\u20131046. https:\/\/doi.org\/10.1016\/j.jhep.2017.01.022","journal-title":"Journal Of Hepatology"},{"issue":"6","key":"2545_CR84","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke, F. 2017. Targeting hepatic macrophages to treat liver diseases. Journal Of Hepatology 66(6):1300\u20131312. https:\/\/doi.org\/10.1016\/j.jhep.2017.02.026","journal-title":"Journal Of Hepatology"},{"issue":"2","key":"2545_CR85","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.31518","volume":"73","author":"H Tilg","year":"2021","unstructured":"Tilg, H., T. E. Adolph, and A. R. Moschen. 2021. Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade. Hepatology 73(2):833\u2013842. https:\/\/doi.org\/10.1002\/hep.31518","journal-title":"Hepatology"},{"key":"2545_CR86","doi-asserted-by":"publisher","first-page":"1437046","DOI":"10.3389\/fimmu.2024.1437046","volume":"15","author":"MN Abdelnabi","year":"2024","unstructured":"Abdelnabi, M. N., G. S. Hassan, and N. H. Shoukry. 2024. Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease. Frontiers In Immunology 15:1437046. https:\/\/doi.org\/10.3389\/fimmu.2024.1437046","journal-title":"Frontiers In Immunology"},{"issue":"9","key":"2545_CR87","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","volume":"61","author":"WK Syn","year":"2012","unstructured":"Syn, W. K., K. M. Agboola, M. Swiderska, G. A. Michelotti, E. Liaskou, H. Pang, G. Xie, G. Philips, I. S. Chan, G. F. Karaca, A. Pereira Tde, Y. Chen, Z. Mi, P. C. Kuo, S. S. Choi, C. D. Guy, M. F. Abdelmalek, and A. M. Diehl. 2012. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 61(9):1323\u20131329. https:\/\/doi.org\/10.1136\/gutjnl-2011-301857","journal-title":"Gut"},{"issue":"3","key":"2545_CR88","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","volume":"53","author":"A Remmerie","year":"2020","unstructured":"Remmerie, A., L. Martens, T. Thon\u00e9, A. Castoldi, R. Seurinck, B. Pavie, J. Roels, B. Vanneste, S. De Prijck, M. Vanhockerhout, M. Binte Abdul Latib, L. Devisscher, A. Hoorens, J. Bonnardel, N. Vandamme, A. Kremer, P. Borghgraef, H. Van Vlierberghe, S. Lippens, E. Pearce, Y. Saeys, and C. L. Scott. 2020. Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver. Immunity 53(3):641\u2013657e14. https:\/\/doi.org\/10.1016\/j.immuni.2020.08.004","journal-title":"Immunity"},{"key":"2545_CR89","doi-asserted-by":"publisher","unstructured":"Xu, Z., F. Xi, X. Deng, Y. Ni, C. Pu, D. Wang, W. Lou, X. Zeng, N. Su, C. Chen, Z. Zeng, L. Deng, and M. Jiang. 2023. Osteopontin promotes macrophage M1 polarization by activation of the JAK1\/STAT1\/HMGB1 signaling pathway in nonalcoholic fatty liver disease. Journal of Clinical and Translational Hepatology 11(2):273\u2013283. 10.14218\/JCTH.2021.00474. Epub 2022 May 31. Erratum in: J Clin Transl Hepatol. 2024;12(1):119\u2013121. https:\/\/doi.org\/10.14218\/JCTH.2021.00474C","DOI":"10.14218\/JCTH.2021.00474C"},{"issue":"2","key":"2545_CR90","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.yexcr.2017.11.035","volume":"362","author":"Y Chen","year":"2018","unstructured":"Chen, Y., Y. Ou, J. Dong, G. Yang, Z. Zeng, Y. Liu, B. Liu, W. Li, X. He, and T. Lan. 2018. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition. Experimental Cell Research 362(2):343\u2013348. https:\/\/doi.org\/10.1016\/j.yexcr.2017.11.035","journal-title":"Experimental Cell Research"},{"issue":"2","key":"2545_CR91","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/1878-0261.13685","volume":"19","author":"M Karin","year":"2025","unstructured":"Karin, M., and J. Y. Kim. 2025. MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives. Molecular Oncology 19(2):275\u2013294. https:\/\/doi.org\/10.1002\/1878-0261.13685","journal-title":"Molecular Oncology"},{"key":"2545_CR92","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3389\/fimmu.2020.01802","volume":"11","author":"X Pan","year":"2020","unstructured":"Pan, X., A. Chiwanda Kaminga, A. Liu, S. W. Wen, J. Chen, and J. Luo. 2020. Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. Frontiers In Immunology 11:1802. https:\/\/doi.org\/10.3389\/fimmu.2020.01802","journal-title":"Frontiers In Immunology"},{"issue":"3","key":"2545_CR93","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","volume":"61","author":"C Baeck","year":"2012","unstructured":"Baeck, C., A. Wehr, K. R. Karlmark, F. Heymann, M. Vucur, N. Gassler, S. Huss, S. Klussmann, D. Eulberg, T. Luedde, C. Trautwein, and F. Tacke. 2012. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61(3):416\u2013426. https:\/\/doi.org\/10.1136\/gutjnl-2011-300304","journal-title":"Gut"},{"key":"2545_CR94","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.trsl.2016.08.006","volume":"180","author":"BH Li","year":"2017","unstructured":"Li, B. H., F. P. He, X. Yang, Y. W. Chen, and J. G. Fan. 2017. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress. Translational Research : The Journal Of Laboratory And Clinical Medicine 180:103\u2013117e4. https:\/\/doi.org\/10.1016\/j.trsl.2016.08.006","journal-title":"Translational Research : The Journal Of Laboratory And Clinical Medicine"},{"issue":"6","key":"2545_CR95","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","volume":"61","author":"X Zhang","year":"2014","unstructured":"Zhang, X., J. Shen, K. Man, E. S. Chu, T. O. Yau, J. C. Sung, M. Y. Go, J. Deng, L. Lu, V. W. Wong, J. J. Sung, G. Farrell, and J. Yu. 2014. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis. Journal Of Hepatology 61(6):1365\u20131375. https:\/\/doi.org\/10.1016\/j.jhep.2014.07.006. Epub 2014 Jul 15.","journal-title":"Journal Of Hepatology"},{"key":"2545_CR96","doi-asserted-by":"publisher","first-page":"175628481881518","DOI":"10.1177\/1756284818815184","volume":"11","author":"W Chen","year":"2018","unstructured":"Chen, W., J. Zhang, H. N. Fan, and J. S. Zhu. 2018. Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease. Therap Adv Gastroenterol 11:1756284818815184. https:\/\/doi.org\/10.1177\/1756284818815184","journal-title":"Therap Adv Gastroenterol"},{"issue":"12","key":"2545_CR97","doi-asserted-by":"publisher","first-page":"101220","DOI":"10.1016\/j.jhepr.2024.101220","volume":"6","author":"BQ Yang","year":"2024","unstructured":"Yang, B. Q., M. M. Chan, G. S. Heo, L. Lou, H. Luehmann, C. Park, A. Li, D. Lahad, D. Sultan, P. Voller, K. Byrnes, C. Fu, Y. Liu, and J. D. Schilling. 2024. Molecular imaging of macrophage composition and dynamics in MASLD. JHEP Rep 6(12):101220. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101220","journal-title":"JHEP Rep"},{"key":"2545_CR98","doi-asserted-by":"publisher","first-page":"1290391","DOI":"10.3389\/fimmu.2023.1290391","volume":"14","author":"A Provera","year":"2023","unstructured":"Provera, A., N. N. Ramavath, L. L. Gadipudi, C. L. Gigliotti, E. Boggio, C. Vecchio, I. Stoppa, R. Rolla, R. Boldorini, M. Pirisi, C. Smirne, E. Albano, U. Dianzani, and S. Sutti. 2023. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis. Frontiers In Immunology 14:1290391. https:\/\/doi.org\/10.3389\/fimmu.2023.1290391","journal-title":"Frontiers In Immunology"},{"issue":"9","key":"2545_CR99","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/CS20150053","volume":"129","author":"S Sutti","year":"2015","unstructured":"Sutti, S., I. Locatelli, S. Bruzz\u00ec, A. Jindal, M. Vacchiano, C. Bozzola, and E. Albano. 2015. CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis. Clin Sci (Lond) 129(9):797\u2013808. https:\/\/doi.org\/10.1042\/CS20150053","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"2545_CR100","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel, O., and F. Tacke. 2017. Liver macrophages in tissue homeostasis and disease. Nature Reviews Immunology 17(5):306\u2013321. https:\/\/doi.org\/10.1038\/nri.2017.11","journal-title":"Nature Reviews Immunology"},{"issue":"3","key":"2545_CR101","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra, F., and F. Tacke. 2014. Roles for chemokines in liver disease. Gastroenterology 147(3):577\u2013594e1. https:\/\/doi.org\/10.1053\/j.gastro.2014.06.043","journal-title":"Gastroenterology"},{"issue":"5","key":"2545_CR102","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/hep.23894","volume":"52","author":"KR Karlmark","year":"2010","unstructured":"Karlmark, K. R., H. W. Zimmermann, C. Roderburg, N. Gassler, H. E. Wasmuth, T. Luedde, C. Trautwein, and F. Tacke. 2010. The fractalkine receptor CX\u2083CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology 52(5):1769\u20131782. https:\/\/doi.org\/10.1002\/hep.23894","journal-title":"Hepatology"},{"issue":"9","key":"2545_CR103","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3390\/cells8091099","volume":"8","author":"S Sutti","year":"2019","unstructured":"Sutti, S., S. Bruzz\u00ec, F. Heymann, A. Liepelt, O. Krenkel, A. Toscani, N. N. Ramavath, D. Cotella, E. Albano, and F. Tacke. 2019. CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation. Cells 8(9):1099. https:\/\/doi.org\/10.3390\/cells8091099","journal-title":"Cells"},{"issue":"17","key":"2545_CR104","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1182\/blood-2010-07-297101","volume":"117","author":"G Scium\u00e8","year":"2011","unstructured":"Scium\u00e8, G., G. De Angelis, G. Benigni, A. Ponzetta, S. Morrone, A. Santoni, and G. Bernardini. 2011. CX3CR1 expression defines 2 KLRG1\u2009+\u2009mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow. Blood 117(17):4467\u20134475. https:\/\/doi.org\/10.1182\/blood-2010-07-297101","journal-title":"Blood"},{"issue":"19","key":"2545_CR105","doi-asserted-by":"publisher","first-page":"7378","DOI":"10.3390\/ijms21197378","volume":"21","author":"I Lurje","year":"2020","unstructured":"Lurje, I., L. Hammerich, and F. Tacke. 2020. Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer. International Journal Of Molecular Sciences 21(19):7378. https:\/\/doi.org\/10.3390\/ijms21197378","journal-title":"International Journal Of Molecular Sciences"},{"issue":"8","key":"2545_CR106","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.jhepr.2025.101414","volume":"7","author":"Y Kim","year":"2025","unstructured":"Kim, Y., Y. Park, H. Rho, T. Yao, B. Gao, and S. Hwang. 2025. Inflammation in MASLD progression and cancer. JHEP Rep 7(8):101414. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101414","journal-title":"JHEP Rep"},{"key":"2545_CR107","doi-asserted-by":"publisher","first-page":"155272","DOI":"10.1016\/j.metabol.2022.155272","volume":"136","author":"Y Ni","year":"2022","unstructured":"Ni, Y., F. Zhuge, L. Ni, N. Nagata, T. Yamashita, N. Mukaida, S. Kaneko, T. Ota, and M. Nagashimada. 2022. CX3CL1\/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1\/M2 status. Metabolism 136:155272. https:\/\/doi.org\/10.1016\/j.metabol.2022.155272","journal-title":"Metabolism"},{"issue":"17","key":"2545_CR108","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1042\/CS20171025","volume":"131","author":"S Sutti","year":"2017","unstructured":"Sutti, S., F. Heymann, S. Bruzz\u00ec, J. Peusquens, C. Trautwein, E. Albano, and F. Tacke. 2017. CX3CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury. Clin Sci (Lond) 131(17):2289\u20132301. https:\/\/doi.org\/10.1042\/CS20171025","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"2545_CR109","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/hep.23795","volume":"52","author":"T Aoyama","year":"2010","unstructured":"Aoyama, T., S. Inokuchi, D. A. Brenner, and E. Seki. 2010. CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology 52(4):1390\u20131400. https:\/\/doi.org\/10.1002\/hep.23795","journal-title":"Hepatology"},{"key":"2545_CR110","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21037\/dmr-21-87","volume":"5","author":"KL Poulsen","year":"2022","unstructured":"Poulsen, K. L., C. K. Cajigas-Du Ross, J. K. Chaney, and L. E. Nagy. 2022. Role of the chemokine system in liver fibrosis: a narrative review. Dig Med Res 5:30. https:\/\/doi.org\/10.21037\/dmr-21-87","journal-title":"Dig Med Res"},{"issue":"9","key":"2545_CR111","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex, R. C. R., and M. J. Watt. 2017. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nature Reviews. Endocrinology 13(9):509\u2013520. https:\/\/doi.org\/10.1038\/nrendo.2017.56","journal-title":"Nature Reviews. Endocrinology"},{"issue":"19","key":"2545_CR112","doi-asserted-by":"publisher","first-page":"10795","DOI":"10.3390\/ijms251910795","volume":"25","author":"I Milani","year":"2024","unstructured":"Milani, I., M. Codini, G. Guarisco, M. Chinucci, C. Gaita, F. Leonetti, D. Capoccia, and Hepatokines. 2024. The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target. International Journal Of Molecular Sciences 25(19):10795. https:\/\/doi.org\/10.3390\/ijms251910795","journal-title":"International Journal Of Molecular Sciences"},{"issue":"8","key":"2545_CR113","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.2851","volume":"18","author":"D Pal","year":"2012","unstructured":"Pal, D., S. Dasgupta, R. Kundu, S. Maitra, G. Das, S. Mukhopadhyay, S. Ray, S. S. Majumdar, and S. Bhattacharya. 2012. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nature Medicine 18(8):1279\u20131285. https:\/\/doi.org\/10.1038\/nm.2851","journal-title":"Nature Medicine"},{"issue":"3","key":"2545_CR114","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2012.258","volume":"9","author":"N Stefan","year":"2013","unstructured":"Stefan, N., and H. U. H\u00e4ring. 2013. The role of hepatokines in metabolism. Nature Reviews. Endocrinology 9(3):144\u2013152. https:\/\/doi.org\/10.1038\/nrendo.2012.258","journal-title":"Nature Reviews. Endocrinology"},{"key":"2545_CR115","doi-asserted-by":"publisher","first-page":"967375","DOI":"10.3389\/fmed.2022.967375","volume":"9","author":"K Falamarzi","year":"2022","unstructured":"Falamarzi, K., M. Malekpour, M. F. Tafti, N. Azarpira, M. Behboodi, and M. Zarei. 2022. The role of FGF21 and its analoguesgs on liver associated diseases. Front Med (Lausanne) 9:967375. https:\/\/doi.org\/10.3389\/fmed.2022.967375","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"2545_CR116","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1210\/jc.2018-02414","volume":"104","author":"D Barb","year":"2019","unstructured":"Barb, D., F. Bril, S. Kalavalapalli, and K. Cusi. 2019. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes. Journal Of Clinical Endocrinology And Metabolism 104(8):3327\u20133336. https:\/\/doi.org\/10.1210\/jc.2018-02414","journal-title":"Journal Of Clinical Endocrinology And Metabolism"},{"issue":"12","key":"2545_CR117","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3390\/biomedicines9121903","volume":"9","author":"TH Kim","year":"2021","unstructured":"Kim, T. H., D. G. Hong, and Y. M. Yang. 2021. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism. Biomedicines 9(12):1903. https:\/\/doi.org\/10.3390\/biomedicines9121903","journal-title":"Biomedicines"},{"issue":"3","key":"2545_CR118","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/path.2708","volume":"221","author":"S Quarta","year":"2010","unstructured":"Quarta, S., L. Vidalino, C. Turato, M. Ruvoletto, F. Calabrese, M. Valente, S. Cannito, G. Fassina, M. Parola, A. Gatta, and P. Pontisso. 2010. SERPINB3 induces epithelial-mesenchymal transition. The Journal Of Pathology 221(3):343\u2013356. https:\/\/doi.org\/10.1002\/path.2708","journal-title":"The Journal Of Pathology"},{"key":"2545_CR119","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2121-15-5","volume":"15","author":"G Villano","year":"2014","unstructured":"Villano, G., C. Turato, S. Quarta, M. Ruvoletto, F. Ciscato, L. Terrin, R. Semeraro, C. Paternostro, M. Parola, D. Alvaro, P. Bernardi, A. Gatta, and P. Pontisso. 2014. Hepatic progenitor cells express SerpinB3. Bmc Cell Biology 15:5. https:\/\/doi.org\/10.1186\/1471-2121-15-5","journal-title":"Bmc Cell Biology"},{"issue":"4","key":"2545_CR120","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/hep.28418","volume":"63","author":"M Bartneck","year":"2016","unstructured":"Bartneck, M., V. Fech, J. Ehling, O. Govaere, K. T. Warzecha, K. Hittatiya, M. Vucur, J. Gautheron, T. Luedde, C. Trautwein, T. Lammers, T. Roskams, W. Jahnen-Dechent, and F. Tacke. 2016. Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. Hepatology 63(4):1310\u20131324. https:\/\/doi.org\/10.1002\/hep.28418","journal-title":"Hepatology"},{"issue":"2","key":"2545_CR121","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/s0168-8278(00)80066-5","volume":"32","author":"MT Levy","year":"2000","unstructured":"Levy, M. T., M. Trojanowska, A. Reuben, and M. Oncostatin. 2000. a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells. Journal Of Hepatology 32(2):218\u2013226. https:\/\/doi.org\/10.1016\/s0168-8278(00)80066-5","journal-title":"Journal Of Hepatology"},{"issue":"1","key":"2545_CR122","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.29421","volume":"67","author":"M Matsuda","year":"2018","unstructured":"Matsuda, M., S. Tsurusaki, N. Miyata, E. Saijou, H. Okochi, A. Miyajima, and M. Tanaka. 2018. Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice. Hepatology 67(1):296\u2013312. https:\/\/doi.org\/10.1002\/hep.29421","journal-title":"Hepatology"},{"key":"2545_CR123","doi-asserted-by":"publisher","first-page":"1239732","DOI":"10.3389\/fimmu.2023.1239732","volume":"14","author":"CL Wolf","year":"2023","unstructured":"Wolf, C. L., C. Pruett, D. Lighter, and C. L. Jorcyk. 2023. The clinical relevance of OSM in inflammatory diseases: a comprehensive review. Frontiers In Immunology 14:1239732. https:\/\/doi.org\/10.3389\/fimmu.2023.1239732","journal-title":"Frontiers In Immunology"},{"key":"2545_CR124","doi-asserted-by":"publisher","first-page":"751802","DOI":"10.3389\/fendo.2021.751802","volume":"12","author":"S Hwang","year":"2021","unstructured":"Hwang, S., H. Yun, S. Moon, Y. E. Cho, and B. Gao. 2021. Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis. Front Endocrinol (Lausanne) 12:751802. https:\/\/doi.org\/10.3389\/fendo.2021.751802","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2545_CR125","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12013-015-0682-9","volume":"73","author":"S Zang","year":"2015","unstructured":"Zang, S., L. Wang, X. Ma, G. Zhu, Z. Zhuang, Y. Xun, F. Zhao, W. Yang, J. Liu, Y. Luo, Y. Liu, D. Ye, and J. Shi. 2015. Neutrophils Play a Crucial Role in the Early Stage of Nonalcoholic Steatohepatitis via Neutrophil Elastase in Mice. Cell Biochemistry And Biophysics 73(2):479\u2013487. https:\/\/doi.org\/10.1007\/s12013-015-0682-9","journal-title":"Cell Biochemistry And Biophysics"},{"issue":"4","key":"2545_CR126","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbrc.2019.08.111","volume":"518","author":"J Chen","year":"2019","unstructured":"Chen, J., B. Liang, D. Bian, Y. Luo, J. Yang, Z. Li, Z. Zhuang, S. Zang, and J. Shi. 2019. Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism. Biochemical And Biophysical Research Communications 518(4):691\u2013697. https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.111","journal-title":"Biochemical And Biophysical Research Communications"},{"issue":"1","key":"2545_CR127","doi-asserted-by":"publisher","first-page":"24194","DOI":"10.1038\/s41598-021-03679-w","volume":"11","author":"AD Kim","year":"2021","unstructured":"Kim, A. D., S. E. Kim, A. Leszczynska, B. Kaufmann, A. Reca, D. J. Kim, and A. E. Feldstein. 2021. Dual role of neutrophils in modulating liver injury and fibrosis during development and resolution of diet-induced murine steatohepatitis. Scientific Reports 11(1):24194. https:\/\/doi.org\/10.1038\/s41598-021-03679-w","journal-title":"Scientific Reports"},{"issue":"3","key":"2545_CR128","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00428-022-03330-7","volume":"481","author":"S Arelaki","year":"2022","unstructured":"Arelaki, S., T. Koletsa, E. Sinakos, V. Papadopoulos, K. Arvanitakis, P. Skendros, E. Akriviadis, K. Ritis, G. Germanidis, and P. Hytiroglou. 2022. Neutrophil extracellular traps enriched with IL-1\u03b2 and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis. Virchows Archiv 481(3):455\u2013465. https:\/\/doi.org\/10.1007\/s00428-022-03330-7","journal-title":"Virchows Archiv"},{"issue":"4","key":"2545_CR129","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.29914","volume":"68","author":"DJ van der Windt","year":"2018","unstructured":"van der Windt, D. J., V. Sud, H. Zhang, P. R. Varley, J. Goswami, H. O. Yazdani, S. Tohme, P. Loughran, R. M. O\u2019Doherty, M. I. Minervini, H. Huang, R. L. Simmons, and A. Tsung. 2018. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology 68(4):1347\u20131360. https:\/\/doi.org\/10.1002\/hep.29914","journal-title":"Hepatology"},{"issue":"3","key":"2545_CR130","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/HEP.0000000000000762","volume":"81","author":"Y Xia","year":"2025","unstructured":"Xia, Y., Y. Wang, Q. Xiong, J. He, H. Wang, M. Islam, X. Zhou, A. Kim, H. Zhang, H. Huang, and A. Tsung. 2025. Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC. Hepatology 81(3):947\u2013961. https:\/\/doi.org\/10.1097\/HEP.0000000000000762","journal-title":"Hepatology"},{"issue":"1","key":"2545_CR131","doi-asserted-by":"publisher","first-page":"101697","DOI":"10.1016\/j.clinre.2021.101697","volume":"46","author":"J Du","year":"2022","unstructured":"Du, J., J. Zhang, X. Chen, S. Zhang, C. Zhang, H. Liu, Y. Li, M. Li, X. Wu, M. Xiang, C. Wang, L. Liu, C. Wang, S. Fang, and J. Shi. 2022. Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients. Clin Res Hepatol Gastroenterol 46(1):101697. https:\/\/doi.org\/10.1016\/j.clinre.2021.101697","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"2545_CR132","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/cancers13040730","volume":"13","author":"M Peiseler","year":"2021","unstructured":"Peiseler, M., and F. Tacke. 2021. Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma. Cancers (Basel) 13(4):730. https:\/\/doi.org\/10.3390\/cancers13040730","journal-title":"Cancers (Basel)"},{"key":"2545_CR133","doi-asserted-by":"publisher","first-page":"156323","DOI":"10.1016\/j.metabol.2025.156323","volume":"170","author":"SH Jo","year":"2025","unstructured":"Jo, S. H., E. S. Lee, S. B. Lee, K. B. Ha, and C. H. Chung. 2025. Synergistic effects of C-C chemokine receptor 2 inhibitor and transforming growth factor-\u03b2 type I receptor kinase inhibitor combination in metabolic dysfunction-associated steatohepatitis. Metabolism 170:156323. https:\/\/doi.org\/10.1016\/j.metabol.2025.156323","journal-title":"Metabolism"},{"key":"2545_CR134","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3389\/fimmu.2019.02893","volume":"10","author":"JR Oates","year":"2019","unstructured":"Oates, J. R., M. C. McKell, M. E. Moreno-Fernandez, M. S. M. A. Damen, G. S. JrDeepe, J. E. Qualls, and S. Divanovic. 2019. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Frontiers In Immunology 10:2893. https:\/\/doi.org\/10.3389\/fimmu.2019.02893","journal-title":"Frontiers In Immunology"},{"issue":"1","key":"2545_CR135","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.ATV.0000251608.09329.9a","volume":"27","author":"T Suganami","year":"2007","unstructured":"Suganami, T., K. Tanimoto-Koyama, J. Nishida, M. Itoh, X. Yuan, S. Mizuarai, H. Kotani, S. Yamaoka, K. Miyake, S. Aoe, Y. Kamei, and Y. Ogawa. 2007. Role of the Toll-like receptor 4\/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arteriosclerosis, Thrombosis, And Vascular Biology 27(1):84\u201391. https:\/\/doi.org\/10.1161\/01.ATV.0000251608.09329.9a","journal-title":"Arteriosclerosis, Thrombosis, And Vascular Biology"},{"key":"2545_CR136","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-1536-3-21","volume":"3","author":"J Guo","year":"2010","unstructured":"Guo, J., and S. L. Friedman. 2010. Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair 3:21. https:\/\/doi.org\/10.1186\/1755-1536-3-21","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"22","key":"2545_CR137","doi-asserted-by":"publisher","first-page":"8602","DOI":"10.3390\/ijms21228602","volume":"21","author":"S Hohenester","year":"2020","unstructured":"Hohenester, S., V. Kanitz, T. Schiergens, C. Einer, J. Nagel, R. Wimmer, F. P. Reiter, A. L. Gerbes, E. N. De Toni, C. Bauer, L. Holdt, D. Mayr, C. Rust, M. Schnurr, H. Zischka, A. Geier, and G. Denk. 2020. IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease. International Journal Of Molecular Sciences 21(22):8602. https:\/\/doi.org\/10.3390\/ijms21228602","journal-title":"International Journal Of Molecular Sciences"},{"issue":"21","key":"2545_CR138","doi-asserted-by":"publisher","first-page":"13251","DOI":"10.3390\/ijms232113251","volume":"23","author":"Y Tada","year":"2022","unstructured":"Tada, Y., K. Kasai, N. Makiuchi, N. Igarashi, K. Kani, S. Takano, H. Honda, T. Yanagibashi, Y. Watanabe, F. Usui-Kawanishi, Y. Furusawa, M. Ichimura-Shimizu, Y. Tabuchi, K. Takatsu, K. Tsuneyama, and Y. Nagai. 2022. Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis. International Journal Of Molecular Sciences 23(21):13251. https:\/\/doi.org\/10.3390\/ijms232113251","journal-title":"International Journal Of Molecular Sciences"},{"issue":"12","key":"2545_CR139","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.3390\/ijms23126649","volume":"23","author":"E Binatti","year":"2022","unstructured":"Binatti, E., A. Gerussi, D. Barisani, and P. Invernizzi. 2022. The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities. International Journal Of Molecular Sciences 23(12):6649. https:\/\/doi.org\/10.3390\/ijms23126649","journal-title":"International Journal Of Molecular Sciences"},{"issue":"5","key":"2545_CR140","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1189\/jlb.5RU0116-016R","volume":"99","author":"L Devisscher","year":"2016","unstructured":"Devisscher, L., X. Verhelst, I. Colle, H. Van Vlierberghe, and A. Geerts. 2016. The role of macrophages in obesity-driven chronic liver disease. Journal Of Leukocyte Biology 99(5):693\u2013698. https:\/\/doi.org\/10.1189\/jlb.5RU0116-016R","journal-title":"Journal Of Leukocyte Biology"},{"issue":"7783","key":"2545_CR141","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran, P., R. Dobie, J. R. Wilson-Kanamori, E. F. Dora, B. E. P. Henderson, N. T. Luu, J. R. Portman, K. P. Matchett, M. Brice, J. A. Marwick, R. S. Taylor, M. Efremova, R. Vento-Tormo, N. O. Carragher, T. J. Kendall, J. A. Fallowfield, E. M. Harrison, D. J. Mole, S. J. Wigmore, P. N. Newsome, C. J. Weston, J. P. Iredale, F. Tacke, J. W. Pollard, C. P. Ponting, J. C. Marioni, S. A. Teichmann, and N. C. Henderson. 2019. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575(7783):512\u2013518. https:\/\/doi.org\/10.1038\/s41586-019-1631-3","journal-title":"Nature"},{"key":"2545_CR142","doi-asserted-by":"publisher","first-page":"867940","DOI":"10.3389\/fendo.2022.867940","volume":"13","author":"JK Carter","year":"2022","unstructured":"Carter, J. K., and S. L. Friedman. 2022. Hepatic Stellate Cell-Immune Interactions in NASH. Front Endocrinol (Lausanne) 13:867940. https:\/\/doi.org\/10.3389\/fendo.2022.867940","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2545_CR143","doi-asserted-by":"publisher","first-page":"1199519","DOI":"10.3389\/fcell.2023.1199519","volume":"11","author":"GX Xu","year":"2023","unstructured":"Xu, G. X., S. Wei, C. Yu, S. Q. Zhao, W. J. Yang, Y. H. Feng, C. Pan, K. X. Yang, and Y. Ma. 2023. Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions. Front Cell Dev Biol 11:1199519. https:\/\/doi.org\/10.3389\/fcell.2023.1199519","journal-title":"Front Cell Dev Biol"},{"key":"2545_CR144","doi-asserted-by":"publisher","first-page":"1150118","DOI":"10.3389\/fendo.2023.1150118","volume":"14","author":"SJ Park","year":"2023","unstructured":"Park, S. J., J. Garcia Diaz, E. Um, and Y. S. Hahn. 2023. Major roles of kupffer cells and macrophages in NAFLD development. Front Endocrinol (Lausanne) 14:1150118. https:\/\/doi.org\/10.3389\/fendo.2023.1150118. PMID: 37274349; PMCID: PMC10235620.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2545_CR145","doi-asserted-by":"publisher","first-page":"1379225","DOI":"10.3389\/fimmu.2024.1379225","volume":"15","author":"AT Pinto","year":"2024","unstructured":"Pinto, A. T., and V. Lukacs-Kornek. 2024. The role of dendritic cells in MASH: friends or foes? Frontiers In Immunology 15:1379225. https:\/\/doi.org\/10.3389\/fimmu.2024.1379225","journal-title":"Frontiers In Immunology"},{"key":"2545_CR146","doi-asserted-by":"publisher","first-page":"641240","DOI":"10.3389\/fimmu.2021.641240","volume":"12","author":"N M\u00e9ndez-S\u00e1nchez","year":"2021","unstructured":"M\u00e9ndez-S\u00e1nchez, N., J. C\u00f3rdova-Gallardo, B. Barranco-Fragoso, and M. Eslam. 2021. Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis. Frontiers In Immunology 12:641240. https:\/\/doi.org\/10.3389\/fimmu.2021.641240","journal-title":"Frontiers In Immunology"},{"issue":"4","key":"2545_CR147","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/vaccines1040527","volume":"1","author":"J Terhune","year":"2013","unstructured":"Terhune, J., E. Berk, and B. J. Czerniecki. 2013. Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy. Vaccines 1(4):527\u2013549. https:\/\/doi.org\/10.3390\/vaccines1040527","journal-title":"Vaccines"},{"key":"2545_CR148","doi-asserted-by":"publisher","first-page":"116333","DOI":"10.1016\/j.biopha.2024.116333","volume":"173","author":"Z Li","year":"2024","unstructured":"Li, Z., S. Wang, Q. Xu, X. Su, Y. Wang, L. Wang, and Y. Zhang. 2024. The double roles of T cell-mediated immune response in the progression of MASLD. Biomedicine & Pharmacotherapy 173:116333. https:\/\/doi.org\/10.1016\/j.biopha.2024.116333","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"2545_CR149","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao, H., L. Wu, G. Yan, Y. Chen, M. Zhou, Y. Wu, and Y. Li. 2021. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 6(1):263. https:\/\/doi.org\/10.1038\/s41392-021-00658-5","journal-title":"Signal Transduct Target Ther"},{"issue":"14","key":"2545_CR150","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/1873-3468.15072","volume":"599","author":"C Klaimi","year":"2025","unstructured":"Klaimi, C., W. Kong, C. Bl\u00e9riot, and J. T. Haas. 2025. The immunological interface: dendritic cells as key regulators in metabolic dysfunction-associated steatotic liver disease. Febs Letters 599(14):1971\u20131981. https:\/\/doi.org\/10.1002\/1873-3468.15072","journal-title":"Febs Letters"},{"issue":"5","key":"2545_CR151","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.3390\/ijms24054565","volume":"24","author":"C Puricelli","year":"2023","unstructured":"Puricelli, C., E. Boggio, C. L. Gigliotti, I. Stoppa, S. Sutti, M. Giordano, U. Dianzani, R. Rolla, and Platelets. 2023. Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications. International Journal Of Molecular Sciences 24(5):4565. https:\/\/doi.org\/10.3390\/ijms24054565","journal-title":"International Journal Of Molecular Sciences"},{"issue":"4","key":"2545_CR152","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3109\/09537104.2015.1010441","volume":"26","author":"CN Jenne","year":"2015","unstructured":"Jenne, C. N., and P. Kubes. 2015. Platelets in inflammation and infection. Platelets 26(4):286\u2013292. https:\/\/doi.org\/10.3109\/09537104.2015.1010441","journal-title":"Platelets"},{"issue":"19","key":"2545_CR153","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1111\/febs.70198","volume":"292","author":"K Kolczy\u0144ska-Matysiak","year":"2025","unstructured":"Kolczy\u0144ska-Matysiak, K., T. Kassouf, D. Stegner, and G. Sumara. 2025. Platelets in the regulation of glucose and lipid metabolism-functions beyond the maintenance of vascular integrity are being revealed. Febs Journal 292(19):4992\u20135007. https:\/\/doi.org\/10.1111\/febs.70198","journal-title":"Febs Journal"},{"key":"2545_CR154","doi-asserted-by":"publisher","first-page":"11385","DOI":"10.2147\/JIR.S533707","volume":"18","author":"T Harm","year":"2025","unstructured":"Harm, T., A. K. Rohlfing, J. K. Henes, N. Manzat, M. Droppa, M. N. Bongers, M. Heikenwaelder, K. A. L. M\u00fcller, M. P. Gawaz, and D. Rath. 2025. Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). J Inflamm Res 18:11385\u201311400. https:\/\/doi.org\/10.2147\/JIR.S533707","journal-title":"J Inflamm Res"},{"issue":"6","key":"2545_CR155","doi-asserted-by":"publisher","first-page":"107615","DOI":"10.1016\/j.celrep.2020.107615","volume":"31","author":"V Rolfes","year":"2020","unstructured":"Rolfes, V., L. S. Ribeiro, I. Hawwari, L. B\u00f6ttcher, N. Rosero, S. Maasewerd, M. L. S. Santos, T. Pr\u00f3chnicki, C. M. S. Silva, C. W. S. Wanderley, M. Rothe, S. V. Schmidt, H. J. Stunden, D. Bertheloot, M. N. Rivas, C. J. Fontes, L. H. Carvalho, F. Q. Cunha, E. Latz, M. Arditi, and B. S. Franklin. 2020. Platelets Fuel the Inflammasome Activation of Innate Immune Cells. Cell Rep 31(6):107615. https:\/\/doi.org\/10.1016\/j.celrep.2020.107615","journal-title":"Cell Rep"},{"key":"2545_CR156","doi-asserted-by":"publisher","first-page":"842636","DOI":"10.3389\/fphar.2022.842636","volume":"13","author":"A Dalbeni","year":"2022","unstructured":"Dalbeni, A., M. Castelli, M. Zoncap\u00e8, P. Minuz, and D. Sacerdoti. 2022. Platelets in Non-alcoholic Fatty Liver Disease. Frontiers In Pharmacology 13:842636. https:\/\/doi.org\/10.3389\/fphar.2022.842636","journal-title":"Frontiers In Pharmacology"},{"issue":"5","key":"2545_CR157","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/jcm13051406","volume":"13","author":"I Minciuna","year":"2024","unstructured":"Minciuna, I., M. G. Taru, B. Procopet, and H. Stefanescu. 2024. The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. J Clin Med 13(5):1406. https:\/\/doi.org\/10.3390\/jcm13051406","journal-title":"J Clin Med"},{"issue":"8","key":"2545_CR158","doi-asserted-by":"publisher","first-page":"e70231","DOI":"10.1111\/liv.70231","volume":"45","author":"M Castelli","year":"2025","unstructured":"Castelli, M., M. Zoncap\u00e8, A. Meneguzzi, A. Mantovani, D. Sacerdoti, P. Minuz, and A. Dalbeni. 2025. Platelet Functional Profile Is Altered in Metabolic Dysfunction-Associated Steatotic Liver Disease. Liver International : Official Journal Of The International Association For The Study Of The Liver 45(8):e70231. https:\/\/doi.org\/10.1111\/liv.70231","journal-title":"Liver International : Official Journal Of The International Association For The Study Of The Liver"},{"key":"2545_CR159","doi-asserted-by":"publisher","first-page":"850836","DOI":"10.1155\/2012\/850836","volume":"2012","author":"K Tajiri","year":"2012","unstructured":"Tajiri, K., and Y. Shimizu. 2012. Role of NKT Cells in the Pathogenesis of NAFLD. Int J Hepatol 2012:850836. https:\/\/doi.org\/10.1155\/2012\/850836","journal-title":"Int J Hepatol"},{"issue":"6","key":"2545_CR160","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/MEG.0b013e32831bc3d6","volume":"21","author":"K Tajiri","year":"2009","unstructured":"Tajiri, K., Y. Shimizu, K. Tsuneyama, and T. Sugiyama. 2009. Role of liver-infiltrating CD3\u2009+\u2009CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. European Journal Of Gastroenterology And Hepatology 21(6):673\u2013680. https:\/\/doi.org\/10.1097\/MEG.0b013e32831bc3d6","journal-title":"European Journal Of Gastroenterology And Hepatology"},{"issue":"6","key":"2545_CR161","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/hep.23599","volume":"51","author":"WK Syn","year":"2010","unstructured":"Syn, W. K., Y. H. Oo, T. A. Pereira, G. F. Karaca, Y. Jung, A. Omenetti, R. P. Witek, S. S. Choi, C. D. Guy, C. M. Fearing, V. Teaberry, F. E. Pereira, D. H. Adams, and A. M. Diehl. 2010. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 51(6):1998\u20132007. https:\/\/doi.org\/10.1002\/hep.23599","journal-title":"Hepatology"},{"issue":"1","key":"2545_CR162","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s42003-025-08872-5","volume":"8","author":"M Papanastasatou","year":"2025","unstructured":"Papanastasatou, M., M. Gioulbasani, E. Nakou, A. Galaras, T. Rubio-Tom\u00e1s, I. Talianidis, A. G. Eliopoulos, P. Hatzis, and M. Verykokakis. 2025. Dual regulatory role of natural killer T cells during development of hepatocellular carcinoma. Commun Biol 8(1):1478. https:\/\/doi.org\/10.1038\/s42003-025-08872-5","journal-title":"Commun Biol"},{"issue":"11","key":"2545_CR163","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","volume":"35","author":"K Sawada","year":"2023","unstructured":"Sawada, K., H. Chung, S. Softic, M. E. Moreno-Fernandez, and S. Divanovic. 2023. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metab 35(11):1852\u20131871. https:\/\/doi.org\/10.1016\/j.cmet.2023.10.009. PMID: 37939656; PMCID: PMC10680147.","journal-title":"Cell Metab"},{"issue":"4","key":"2545_CR164","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1042\/CS20120289","volume":"124","author":"I Locatelli","year":"2013","unstructured":"Locatelli, I., S. Sutti, M. Vacchiano, C. Bozzola, and E. Albano. 2013. NF-\u03baB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses. Clin Sci (Lond) 124(4):279\u2013287. https:\/\/doi.org\/10.1042\/CS20120289","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"2545_CR165","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","volume":"17","author":"S Sutti","year":"2020","unstructured":"Sutti, S., and E. Albano. 2020. Adaptive immunity: an emerging player in the progression of NAFLD. Nature Reviews. Gastroenterology & Hepatology 17(2):81\u201392. https:\/\/doi.org\/10.1038\/s41575-019-0210-2","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"2","key":"2545_CR166","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/HEP.0000000000000971","volume":"81","author":"AEC Burtis","year":"2025","unstructured":"Burtis, A. E. C., D. M. C. DeNicola, M. E. Ferguson, R. G. Santos, C. Pinilla, M. S. Kriss, D. J. Orlicky, B. A. J. Tamburini, A. E. Gillen, and M. A. Burchill. 2025. Ag-driven CD8\u2009+\u2009T cell clonal expansion is a prominent feature of MASH in humans and mice. Hepatology 81(2):591\u2013608. https:\/\/doi.org\/10.1097\/HEP.0000000000000971","journal-title":"Hepatology"},{"issue":"3","key":"2545_CR167","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.26749","volume":"59","author":"S Sutti","year":"2014","unstructured":"Sutti, S., A. Jindal, I. Locatelli, M. Vacchiano, L. Gigliotti, C. Bozzola, and E. Albano. 2014. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology 59(3):886\u2013897. https:\/\/doi.org\/10.1002\/hep.26749","journal-title":"Hepatology"},{"issue":"2","key":"2545_CR168","doi-asserted-by":"publisher","first-page":"112801","DOI":"10.1016\/j.yexcr.2021.112801","volume":"407","author":"L Li","year":"2021","unstructured":"Li, L., Y. Xia, X. Ji, H. Wang, Z. Zhang, P. Lu, Q. Ding, D. Wang, and M. Liu. 2021. MIG\/CXCL9 exacerbates the progression of metabolic-associated fatty liver disease by disrupting Treg\/Th17 balance. Experimental Cell Research 407(2):112801. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112801","journal-title":"Experimental Cell Research"},{"key":"2545_CR169","doi-asserted-by":"publisher","first-page":"967410","DOI":"10.3389\/fimmu.2022.967410","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y., H. Zhang, Y. Yao, X. Zhang, Y. Guan, and F. Zheng. 2022. CD4\u2009+\u2009T cell activation and inflammation in NASH-related fibrosis. Frontiers In Immunology 13:967410. https:\/\/doi.org\/10.3389\/fimmu.2022.967410","journal-title":"Frontiers In Immunology"},{"issue":"4","key":"2545_CR170","doi-asserted-by":"publisher","first-page":"e2149641","DOI":"10.1002\/eji.202149641","volume":"54","author":"K Mladeni\u0107","year":"2024","unstructured":"Mladeni\u0107, K., M. Lenarti\u0107, S. Marinovi\u0107, B. Poli\u0107, and F. M. Wensveen. 2024. The Domino effect in MASLD: The inflammatory cascade of steatohepatitis. European Journal Of Immunology 54(4):e2149641. https:\/\/doi.org\/10.1002\/eji.202149641","journal-title":"European Journal Of Immunology"},{"issue":"1","key":"2545_CR171","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","volume":"30","author":"AL Gomes","year":"2016","unstructured":"Gomes, A. L., A. Teijeiro, S. Bur\u00e9n, K. S. Tummala, M. Yilmaz, A. Waisman, J. P. Theurillat, C. Perna, and N. Djouder. 2016. Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma. Cancer Cell 30(1):161\u2013175. https:\/\/doi.org\/10.1016\/j.ccell.2016.05.020","journal-title":"Cancer Cell"},{"key":"2545_CR172","doi-asserted-by":"publisher","first-page":"1279837","DOI":"10.3389\/fimmu.2023.1279837","volume":"14","author":"X Fan","year":"2023","unstructured":"Fan, X., P. Shu, Y. Wang, N. Ji, and D. Zhang. 2023. Interactions between neutrophils and T-helper 17 cells. Frontiers In Immunology 14:1279837. https:\/\/doi.org\/10.3389\/fimmu.2023.1279837","journal-title":"Frontiers In Immunology"},{"issue":"5","key":"2545_CR173","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/hep.21823","volume":"46","author":"X Ma","year":"2007","unstructured":"Ma, X., J. Hua, A. R. Mohamood, A. R. Hamad, R. Ravi, and Z. Li. 2007. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46(5):1519\u20131529. https:\/\/doi.org\/10.1002\/hep.21823","journal-title":"Hepatology"},{"issue":"8","key":"2545_CR174","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nm.2002","volume":"15","author":"M Feuerer","year":"2009","unstructured":"Feuerer, M., L. Herrero, D. Cipolletta, A. Naaz, J. Wong, A. Nayer, J. Lee, A. B. Goldfine, C. Benoist, S. Shoelson, and D. Mathis. 2009. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine 15(8):930\u2013939. https:\/\/doi.org\/10.1038\/nm.2002","journal-title":"Nature Medicine"},{"issue":"23","key":"2545_CR175","doi-asserted-by":"publisher","first-page":"e175305","DOI":"10.1172\/JCI175305","volume":"134","author":"D Aki","year":"2024","unstructured":"Aki, D., T. Hayakawa, T. Srirat, S. Shichino, M. Ito, S. I. Saitoh, S. Mise-Omata, and A. Yoshimura. 2024. The Nr4a family regulates intrahepatic Treg proliferation and liver fibrosis in MASLD models. J Clin Invest 134(23):e175305. https:\/\/doi.org\/10.1172\/JCI175305","journal-title":"J Clin Invest"},{"issue":"2","key":"2545_CR176","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/hep4.1807","volume":"6","author":"J Dywicki","year":"2022","unstructured":"Dywicki, J., L. E. Buitrago-Molina, F. Noyan, A. C. Davalos-Misslitz, K. L. Hupa-Breier, M. Lieber, M. Hapke, J. Schlue, C. S. Falk, S. Raha, I. Prinz, C. Koenecke, M. P. Manns, H. Wedemeyer, M. Hardtke-Wolenski, and E. Jaeckel. 2022. The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis. Hepatol Commun 6(2):320\u2013333. https:\/\/doi.org\/10.1002\/hep4.1807","journal-title":"Hepatol Commun"},{"issue":"2","key":"2545_CR177","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","volume":"57","author":"TM Savage","year":"2024","unstructured":"Savage, T. M., K. T. Fortson, K. de Los Santos-Alexis, A. Oliveras-Alsina, M. Rouanne, S. S. Rae, J. R. Gamarra, H. Shayya, A. Kornberg, R. Cavero, F. Li, A. Han, R. A. Haeusler, J. Adam, R. F. Schwabe, and N. Arpaia. 2024. Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis. Immunity 57(2):303\u2013318e6. https:\/\/doi.org\/10.1016\/j.immuni.2024.01.009","journal-title":"Immunity"},{"issue":"6","key":"2545_CR178","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","volume":"75","author":"H Wang","year":"2021","unstructured":"Wang, H., H. Zhang, Y. Wang, Z. J. Brown, Y. Xia, Z. Huang, C. Shen, Z. Hu, J. Beane, E. A. Ansa-Addo, H. Huang, D. Tian, and A. Tsung. 2021. Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis. Journal Of Hepatology 75(6):1271\u20131283. https:\/\/doi.org\/10.1016\/j.jhep.2021.07.032","journal-title":"Journal Of Hepatology"},{"key":"2545_CR179","doi-asserted-by":"publisher","first-page":"105031","DOI":"10.1016\/j.ebiom.2024.105031","volume":"101","author":"H Wang","year":"2024","unstructured":"Wang, H., A. Tsung, L. Mishra, H. Huang, and T. Regulatory. 2024. cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma. EBioMedicine 101:105031. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105031","journal-title":"EBioMedicine"},{"issue":"10","key":"2545_CR180","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.cmet.2024.08.005","volume":"36","author":"W Liu","year":"2024","unstructured":"Liu, W., D. You, J. Lin, H. Zou, L. Zhang, S. Luo, Y. Yuan, Z. Wang, J. Qi, W. Wang, X. Ye, X. Yang, Y. Deng, F. Teng, X. Zheng, Y. Lin, Z. Huang, Y. Huang, Z. Yang, X. Zhou, Y. Zhang, R. Chen, L. Xu, J. Li, W. Yang, and H. Zhang. 2024. SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8\u2009+\u2009T cell activation. Cell Metab 36(10):2245\u20132261e6. https:\/\/doi.org\/10.1016\/j.cmet.2024.08.005","journal-title":"Cell Metab"},{"issue":"6","key":"2545_CR181","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41591-021-01344-3","volume":"27","author":"A Deczkowska","year":"2021","unstructured":"Deczkowska, A., E. David, P. Ramadori, D. Pfister, M. Safran, B. Li, A. Giladi, D. A. Jaitin, O. Barboy, M. Cohen, I. Yofe, C. Gur, S. Shlomi-Loubaton, S. Henri, Y. Suhail, M. Qiu, S. Kam, H. Hermon, E. Lahat, G. Ben Yakov, O. Cohen-Ezra, Y. Davidov, M. Likhter, D. Goitein, S. Roth, A. Weber, B. Malissen, A. Weiner, Z. Ben-Ari, M. Heikenw\u00e4lder, E. Elinav, and I. Amit. 2021. XCR1\u2009+\u2009type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. Nature Medicine 27(6):1043\u20131054. https:\/\/doi.org\/10.1038\/s41591-021-01344-3","journal-title":"Nature Medicine"},{"key":"2545_CR182","doi-asserted-by":"publisher","unstructured":"Ma, C., S. Wang, B. Dong, and Y. Tian. 2025. Metabolic reprogramming of immune cells in MASH. Hepatology 5. https:\/\/doi.org\/10.1097\/HEP.0000000000001371. Epub ahead of print. PMID: 40324062","DOI":"10.1097\/HEP.0000000000001371"},{"key":"2545_CR183","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2018.06.015","volume":"124","author":"S Bruzz\u00ec","year":"2018","unstructured":"Bruzz\u00ec, S., S. Sutti, G. Giudici, M. E. Burlone, N. N. Ramavath, A. Toscani, C. Bozzola, P. Schneider, E. Morello, M. Parola, M. Pirisi, and E. Albano. 2018. B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD). Free Radical Biology And Medicine 124:249\u2013259. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.06.015","journal-title":"Free Radical Biology And Medicine"},{"key":"2545_CR184","doi-asserted-by":"publisher","first-page":"1447391","DOI":"10.3389\/fimmu.2024.1447391","volume":"15","author":"H Li","year":"2024","unstructured":"Li, H., and N. Xia. 2024. The multifaceted roles of B lymphocytes in metabolic dysfunction-associated steatotic liver disease. Frontiers In Immunology 15:1447391. https:\/\/doi.org\/10.3389\/fimmu.2024.1447391","journal-title":"Frontiers In Immunology"},{"issue":"1","key":"2545_CR185","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7150\/ijms.101492","volume":"22","author":"S Jiang","year":"2025","unstructured":"Jiang, S., J. Lu, N. Li, X. Bai, L. Shi, Z. Tian, J. Zhou, and W. Zhang. 2025. Liver B Cells Promotes MASLD Progression via the Apelin\/APLNR System. International Journal Of Medical Sciences 22(1):197\u2013208. https:\/\/doi.org\/10.7150\/ijms.101492","journal-title":"International Journal Of Medical Sciences"},{"issue":"1","key":"2545_CR186","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12943-024-02001-2","volume":"23","author":"Y Xie","year":"2024","unstructured":"Xie, Y., Y. Huang, Z. Y. Li, W. Jiang, N. X. Shi, Y. Lu, G. Cao, Z. Yin, and X. J. Lin. 2024. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA\u2009+\u2009B cells. Molecular Cancer 23(1):95. https:\/\/doi.org\/10.1186\/s12943-024-02001-2","journal-title":"Molecular Cancer"},{"issue":"2","key":"2545_CR187","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/hep.31755","volume":"74","author":"F Barrow","year":"2021","unstructured":"Barrow, F., S. Khan, G. Fredrickson, H. Wang, K. Dietsche, P. Parthiban, S. Robert, T. Kaiser, S. Winer, A. Herman, O. Adeyi, M. Mouzaki, A. Khoruts, K. A. Hogquist, C. Staley, D. A. Winer, and X. S. Revelo. 2021. Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling. Hepatology 74(2):704\u2013722. https:\/\/doi.org\/10.1002\/hep.31755","journal-title":"Hepatology"},{"issue":"5","key":"2545_CR188","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/ATVBAHA.119.312467","volume":"40","author":"P Srikakulapu","year":"2020","unstructured":"Srikakulapu, P., and C. A. McNamara. 2020. B Lymphocytes and Adipose Tissue Inflammation. Arteriosclerosis, Thrombosis, And Vascular Biology 40(5):1110\u20131122. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312467","journal-title":"Arteriosclerosis, Thrombosis, And Vascular Biology"},{"issue":"7","key":"2545_CR189","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/1751-2980.12362","volume":"17","author":"F Zhang","year":"2016","unstructured":"Zhang, F., W. W. Jiang, X. Li, X. Y. Qiu, Z. Wu, Y. J. Chi, X. Cong, and Y. L. Liu. 2016. Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells. J Dig Dis 17(7):464\u2013474. https:\/\/doi.org\/10.1111\/1751-2980.12362","journal-title":"J Dig Dis"},{"key":"2545_CR190","doi-asserted-by":"publisher","unstructured":"Barrow, F., H. Wang, G. Fredrickson, K. Florczak, E. Ciske, S. Khanal, P. Parthiban, H. Nguyen, E. Rios, E. Kostallari, and X. S. Revelo. 2023. Pyruvate oxidation sustains B cell antigen-specific activation to exacerbate MASH. bioRxiv [Preprint]. 15:2023.11.13.566832. https:\/\/doi.org\/10.1101\/2023.11.13.566832","DOI":"10.1101\/2023.11.13.566832"},{"issue":"2","key":"2545_CR191","doi-asserted-by":"publisher","first-page":"e70322","DOI":"10.1096\/fj.202401256R","volume":"39","author":"NH Kim","year":"2025","unstructured":"Kim, N. H., M. Y. Kim, Y. M. Yang, W. I. Jeong, H. W. Lee, W. Kim, S. G. Kang, and Y. H. Han. 2025. Bacterial components-driven intrahepatic CXCR5hi B cells are important population for MASH progression through inducing inflammation. The Faseb Journal 39(2):e70322. https:\/\/doi.org\/10.1096\/fj.202401256R","journal-title":"The Faseb Journal"},{"key":"2545_CR192","doi-asserted-by":"publisher","first-page":"607011","DOI":"10.3389\/fendo.2020.607011","volume":"11","author":"T Hendrikx","year":"2020","unstructured":"Hendrikx, T., and C. J. Binder. 2020. Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 11:607011. https:\/\/doi.org\/10.3389\/fendo.2020.607011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2545_CR193","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/hep.23228","volume":"50","author":"SS Rensen","year":"2009","unstructured":"Rensen, S. S., Y. Slaats, A. Driessen, C. J. Peutz-Kootstra, J. Nijhuis, R. Steffensen, J. W. Greve, and W. A. Buurman. 2009. Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology 50(6):1809\u20131817. https:\/\/doi.org\/10.1002\/hep.23228","journal-title":"Hepatology"},{"issue":"4","key":"2545_CR194","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/hep.32428","volume":"76","author":"M Karl","year":"2022","unstructured":"Karl, M., S. Hasselwander, Y. Zhou, G. Reifenberg, Y. O. Kim, K. S. Park, D. A. Ridder, X. Wang, E. Seidel, N. H\u00f6velmeyer, B. K. Straub, H. Li, D. Schuppan, and N. Xia. 2022. Dual roles of B lymphocytes in mouse models of diet-induced nonalcoholic fatty liver disease. Hepatology 76(4):1135\u20131149. https:\/\/doi.org\/10.1002\/hep.32428","journal-title":"Hepatology"},{"issue":"2","key":"2545_CR195","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jhep.2023.04.037","volume":"79","author":"E Kotsiliti","year":"2023","unstructured":"Kotsiliti, E., V. Leone, S. Schuehle, O. Govaere, H. Li, M. J. Wolf, H. Horvatic, S. Bierwirth, J. Hundertmark, D. Inverso, L. Zizmare, A. Sarusi-Portuguez, R. Gupta, T. O\u2019Connor, A. D. Giannou, A. M. Shiri, Y. Schlesinger, M. G. Beccaria, C. Rennert, D. Pfister, R. \u00d6llinger, I. Gadjalova, P. Ramadori, M. Rahbari, N. Rahbari, M. E. Healy, M. Fern\u00e1ndez-Vaquero, N. Yahoo, J. Janzen, I. Singh, C. Fan, X. Liu, M. Rau, M. Feuchtenberger, E. Schwaneck, S. J. Wallace, S. Cockell, J. Wilson-Kanamori, P. Ramachandran, C. Kho, T. J. Kendall, A. L. Leblond, S. J. Keppler, P. Bielecki, K. Steiger, M. Hofmann, K. Rippe, H. Zitzelsberger, A. Weber, N. Malek, T. Luedde, M. Vucur, H. G. Augustin, R. Flavell, O. Parnas, R. Rad, O. Pabst, N. C. Henderson, S. Huber, A. Macpherson, P. Knolle, M. Claassen, A. Geier, C. Trautwein, K. Unger, E. Elinav, A. Waisman, Z. Abdullah, D. Haller, F. Tacke, Q. M. Anstee, and M. Heikenwalder. 2023. Intestinal B cells license metabolic T-cell activation in NASH microbiota\/antigen-independently and contribute to fibrosis by IgA-FcR signalling. Journal Of Hepatology 79(2):296\u2013313. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.037","journal-title":"Journal Of Hepatology"},{"issue":"13","key":"2545_CR196","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1016\/j.celrep.2018.12.006","volume":"25","author":"G Sun","year":"2018","unstructured":"Sun, G., H. Jin, C. Zhang, H. Meng, X. Zhao, D. Wei, X. Ou, Q. Wang, S. Li, T. Wang, X. Sun, W. Shi, D. Tian, K. Liu, H. Xu, Y. Tian, X. Li, W. Guo, J. Jia, Z. Zhang, and D. Zhang. 2018. OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis. Cell Rep 25(13):3786\u20133799e4. https:\/\/doi.org\/10.1016\/j.celrep.2018.12.006","journal-title":"Cell Rep"},{"issue":"4","key":"2545_CR197","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/hep.28970","volume":"65","author":"CJ Busch","year":"2017","unstructured":"Busch, C. J., T. Hendrikx, D. Weismann, S. J\u00e4ckel, S. M. Walenbergh, A. F. Rendeiro, J. Wei\u00dfer, F. Puhm, A. Hladik, L. G\u00f6derle, N. Papac-Milicevic, G. Haas, V. Millischer, S. Subramaniam, S. Knapp, K. L. Bennett, C. Bock, C. Reinhardt, R. Shiri-Sverdlov, and C. J. Binder. 2017. Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice. Hepatology 65(4):1181\u20131195. https:\/\/doi.org\/10.1002\/hep.28970","journal-title":"Hepatology"},{"key":"2545_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12953-019-0149-9","volume":"17","author":"P Chienwichai","year":"2019","unstructured":"Chienwichai, P., O. Reamtong, U. Boonyuen, T. Pisitkun, P. Somparn, P. Tharnpoophasiam, S. Worakhunpiset, and S. Topanurak. 2019. Hepatic protein Carbonylation profiles induced by lipid accumulation and oxidative stress for investigating cellular response to non-alcoholic fatty liver disease in vitro. Proteome Sci 17:1. https:\/\/doi.org\/10.1186\/s12953-019-0149-9","journal-title":"Proteome Sci"},{"issue":"4","key":"2545_CR199","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.autrev.2004.11.011","volume":"4","author":"H Ohmori","year":"2005","unstructured":"Ohmori, H., and N. Kanayama. 2005. Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun Rev 4(4):224\u2013229. https:\/\/doi.org\/10.1016\/j.autrev.2004.11.011","journal-title":"Autoimmun Rev"},{"key":"2545_CR200","doi-asserted-by":"publisher","first-page":"112789","DOI":"10.1016\/j.biopha.2022.112789","volume":"148","author":"ME Shaker","year":"2022","unstructured":"Shaker, M. E. 2022. The contribution of sterile inflammation to the fatty liver disease and the potential therapies. Biomedicine & Pharmacotherapy 148:112789. https:\/\/doi.org\/10.1016\/j.biopha.2022.112789","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"2545_CR201","doi-asserted-by":"publisher","first-page":"14702","DOI":"10.1038\/s41598-019-50976-6","volume":"9","author":"S Aarts","year":"2019","unstructured":"Aarts, S., M. Reiche, M. den Toom, M. Gijbels, L. Beckers, N. Gerdes, and E. Lutgens. 2019. Depletion of CD40 on CD11c+ cells worsens the metabolic syndrome and ameliorates hepatic inflammation during NASH. Scientific Reports 9(1):14702.","journal-title":"Scientific Reports"},{"key":"2545_CR202","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3389\/fimmu.2019.01325","volume":"10","author":"C Carenza","year":"2019","unstructured":"Carenza, C., F. Calcaterra, F. Oriolo, C. Di Vito, M. Ubezio, M. G. Della Porta, D. Mavilio, and S. Della Bella. 2019. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells. Frontiers In Immunology 10:1325.","journal-title":"Frontiers In Immunology"},{"issue":"10","key":"2545_CR203","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1111\/j.1600-6143.2012.04180.x","volume":"12","author":"CN Magee","year":"2012","unstructured":"Magee, C. N., O. Boenisch, and N. Najafian. 2012. The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells. American Journal Of Transplantation 12(10):2588\u20132600. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04180.x","journal-title":"American Journal Of Transplantation"},{"issue":"1","key":"2545_CR204","doi-asserted-by":"publisher","first-page":"ltae004","DOI":"10.1093\/immadv\/ltae004","volume":"4","author":"A Patel","year":"2024","unstructured":"Patel, A., M. A. Kutuzov, M. L. Dustin, P. A. van der Merwe, and O. Dushek. 2024. Regulation of temporal cytokine production by co-stimulation receptors in TCR-T cells is lost in CAR-T cells. Immunother Adv 4(1):ltae004. https:\/\/doi.org\/10.1093\/immadv\/ltae004","journal-title":"Immunother Adv"},{"issue":"4","key":"2545_CR205","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/hep.27233","volume":"60","author":"A Chatzigeorgiou","year":"2014","unstructured":"Chatzigeorgiou, A., K. J. Chung, R. Garcia-Martin, V. I. Alexaki, A. Klotzsche-von Ameln, J. Phieler, D. Sprott, W. Kanczkowski, T. Tzanavari, M. Bdeir, S. Bergmann, M. Cartellieri, M. Bachmann, P. Nikolakopoulou, A. Androutsellis-Theotokis, G. Siegert, S. R. Bornstein, M. H. Muders, L. Boon, K. P. Karalis, E. Lutgens, and T. Chavakis. 2014. Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. Hepatology 60(4):1196\u20131210. https:\/\/doi.org\/10.1002\/hep.27233","journal-title":"Hepatology"},{"key":"2545_CR206","doi-asserted-by":"publisher","first-page":"1445634","DOI":"10.3389\/fimmu.2024.1445634","volume":"15","author":"M Cebi","year":"2024","unstructured":"Cebi, M., and Y. Yilmaz. 2024. Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes. Frontiers In Immunology 15:1445634. https:\/\/doi.org\/10.3389\/fimmu.2024.1445634","journal-title":"Frontiers In Immunology"},{"issue":"1","key":"2545_CR207","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.31644","volume":"74","author":"E Pose","year":"2021","unstructured":"Pose, E., M. Coll, C. Mart\u00ednez-S\u00e1nchez, Z. Zeng, B. G. J. Surewaard, C. Catal\u00e0, M. Velasco-de Andr\u00e9s, J. J. Lozano, S. Ari\u00f1o, D. Fuster, A. Ni\u00f1erola-Baz\u00e1n, I. Graupera, \u00c9 Mu\u00f1oz, F. Lozano, P. Sancho-Bru, P. Kubes, and P. Gin\u00e8s. 2021. Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections. Hepatology 74(1):296\u2013311. https:\/\/doi.org\/10.1002\/hep.31644","journal-title":"Hepatology"},{"key":"2545_CR208","doi-asserted-by":"publisher","first-page":"5954437","DOI":"10.1155\/2022\/5954437","volume":"2022","author":"G Dong","year":"2022","unstructured":"Dong, G., X. Huang, R. Chen, L. Wu, S. Jiang, and S. Chen. 2022. Increased PD-L1 Restricts Liver Injury in Nonalcoholic Fatty Liver Disease. Oxid Med Cell Longev 2022:5954437. https:\/\/doi.org\/10.1155\/2022\/5954437","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"2545_CR209","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.3390\/ijms25073671","volume":"25","author":"RM Pipitone","year":"2024","unstructured":"Pipitone, R. M., G. Lupo, R. Zito, A. Javed, S. Petta, G. Pennisi, and S. Grimaudo. 2024. The PD-1\/PD-L1 Axis in the Biology of MASLD. International Journal Of Molecular Sciences 25(7):3671. https:\/\/doi.org\/10.3390\/ijms25073671","journal-title":"International Journal Of Molecular Sciences"},{"issue":"7854","key":"2545_CR210","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister, D., N. G. N\u00fa\u00f1ez, R. Pinyol, O. Govaere, M. Pinter, M. Szydlowska, R. Gupta, M. Qiu, A. Deczkowska, A. Weiner, F. M\u00fcller, A. Sinha, E. Friebel, T. Engleitner, D. Lenggenhager, A. Moncsek, D. Heide, K. Stirm, J. Kosla, E. Kotsiliti, V. Leone, M. Dudek, S. Yousuf, D. Inverso, I. Singh, A. Teijeiro, F. Castet, C. Montironi, P. K. Haber, D. Tiniakos, P. Bedossa, S. Cockell, R. Younes, M. Vacca, F. Marra, J. M. Schattenberg, M. Allison, E. Bugianesi, V. Ratziu, T. Pressiani, A. D\u2019Alessio, N. Personeni, L. Rimassa, A. K. Daly, B. Scheiner, K. Pomej, M. M. Kirstein, A. Vogel, M. Peck-Radosavljevic, F. Hucke, F. Finkelmeier, O. Waidmann, J. Trojan, K. Schulze, H. Wege, S. Koch, A. Weinmann, M. Bueter, F. R\u00f6ssler, A. Siebenh\u00fcner, S. De Dosso, J. P. Mallm, V. Umansky, M. Jugold, T. Luedde, A. Schietinger, P. Schirmacher, B. Emu, H. G. Augustin, A. Billeter, B. M\u00fcller-Stich, H. Kikuchi, D. G. Duda, F. K\u00fctting, D. T. Waldschmidt, M. P. Ebert, N. Rahbari, H. E. Mei, A. R. Schulz, M. Ringelhan, N. Malek, S. Spahn, M. Bitzer, M. de Ruiz, A. Lujambio, J. F. Dufour, T. U. Marron, A. Kaseb, M. Kudo, Y. H. Huang, N. Djouder, K. Wolter, L. Zender, P. N. Marche, T. Decaens, D. J. Pinato, R. Rad, J. C. Mertens, A. Weber, K. Unger, F. Meissner, S. Roth, Z. M. Jilkova, M. Claassen, Q. M. Anstee, I. Amit, P. Knolle, B. Becher, J. M. Llovet, and M. Heikenwalder. 2021. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature 592(7854):450\u2013456. https:\/\/doi.org\/10.1038\/s41586-021-03362-0","journal-title":"Nature"},{"issue":"6","key":"2545_CR211","doi-asserted-by":"publisher","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang, Y., Y. Li, and B. Zhu. 2015. T-cell exhaustion in the tumor microenvironment. Cell Death And Disease 6(6):e1792. https:\/\/doi.org\/10.1038\/cddis.2015.162","journal-title":"Cell Death And Disease"},{"key":"2545_CR212","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","volume":"23","author":"RJ Greenwald","year":"2005","unstructured":"Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annual Review Of Immunology 23:515\u2013548. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115611","journal-title":"Annual Review Of Immunology"},{"issue":"2","key":"2545_CR213","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4049\/jimmunol.180.2.774","volume":"180","author":"Y Burmeister","year":"2008","unstructured":"Burmeister, Y., T. Lischke, A. C. Dahler, H. W. Mages, K. P. Lam, A. J. Coyle, R. A. Kroczek, and A. Hutloff. 2008. ICOS controls the pool size of effector-memory and regulatory T cells. The Journal Of Immunology 180(2):774\u2013782. https:\/\/doi.org\/10.4049\/jimmunol.180.2.774","journal-title":"The Journal Of Immunology"},{"issue":"12","key":"2545_CR214","doi-asserted-by":"publisher","first-page":"e82203","DOI":"10.1371\/journal.pone.0082203","volume":"8","author":"J Zheng","year":"2013","unstructured":"Zheng, J., P. L. Chan, Y. Liu, G. Qin, Z. Xiang, K. T. Lam, D. B. Lewis, Y. L. Lau, and W. Tu. 2013. ICOS regulates the generation and function of human CD4\u2009+\u2009Treg in a CTLA-4 dependent manner. PLoS One 8(12):e82203. https:\/\/doi.org\/10.1371\/journal.pone.0082203","journal-title":"PLoS One"},{"issue":"2","key":"2545_CR215","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.20020632","volume":"197","author":"M L\u00f6hning","year":"2003","unstructured":"L\u00f6hning, M., A. Hutloff, T. Kallinich, H. W. Mages, K. Bonhagen, A. Radbruch, E. Hamelmann, and R. A. Kroczek. 2003. Expression of ICOS in vivo defines CD4\u2009+\u2009effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. Journal Of Experimental Medicine 197(2):181\u2013193. https:\/\/doi.org\/10.1084\/jem.20020632","journal-title":"Journal Of Experimental Medicine"},{"issue":"2","key":"2545_CR216","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/hep.30952","volume":"71","author":"A Torres-Hernandez","year":"2020","unstructured":"Torres-Hernandez, A., W. Wang, Y. Nikiforov, K. Tejada, L. Torres, A. Kalabin, S. Adam, J. Wu, L. Lu, R. Chen, A. Lemmer, J. Camargo, M. Hundeyin, B. Diskin, B. Aykut, E. Kurz, J. A. Kochen Rossi, M. Khan, M. Liria, G. Sanchez, N. Wu, W. Su, S. Adams, M. I. U. Haq, M. S. Farooq, V. Vasudevaraja, J. Leinwand, and G. Miller. 2020. \u03b3\u03b4 T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming. Hepatology 71(2):477\u2013494. https:\/\/doi.org\/10.1002\/hep.30952","journal-title":"Hepatology"},{"key":"2545_CR217","doi-asserted-by":"publisher","unstructured":"Vecchio, C., A. Provera, L. L. Gadipudi, N. N. Ramavath, R. Boldorini, N. Clemente, L. C. Gigliotti, E. Boggio, U. Dianzani, E. Albano, and S. Sutti. 2023. Co-stimulatory signals mediated by inducible T-cell co-stimulator (ICOS) influence the hepatic expansion auto-aggressive CD8\u2009+\u2009T-cells in non-alcoholic steatohepatitis (NASH). Journal of Hepatology 78(Supplement 1): S751. ISSN: 0168\u20138278. https:\/\/doi.org\/10.1016\/s0168-8278(23)02160-8. ISSN: 0168\u20138278.","DOI":"10.1016\/s0168-8278(23)02160-8"},{"issue":"738","key":"2545_CR218","doi-asserted-by":"publisher","first-page":"eadk1866","DOI":"10.1126\/scitranslmed.adk1866","volume":"16","author":"L Zhou","year":"2024","unstructured":"Zhou, L., X. Qiu, Z. Meng, T. Liu, Z. Chen, P. Zhang, H. Kuang, T. Pan, Y. Lu, L. Qi, D. P. Olson, X. Z. S. Xu, Y. E. Chen, S. Li, and J. D. Lin. 2024. Hepatic danger signaling triggers TREM2\u2009+\u2009macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation. Science Translational Medicine 16(738):eadk1866. https:\/\/doi.org\/10.1126\/scitranslmed.adk1866","journal-title":"Science Translational Medicine"},{"issue":"5","key":"2545_CR219","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jhep.2022.06.004","volume":"77","author":"T Hendrikx","year":"2022","unstructured":"Hendrikx, T., F. Porsch, M. G. Kiss, D. Rajcic, N. Papac-Mili\u010devi\u0107, C. Hoebinger, L. Goederle, A. Hladik, L. E. Shaw, H. Horstmann, S. Knapp, S. Derdak, M. Bilban, L. Heintz, M. Krawczyk, R. Paternostro, M. Trauner, M. Farlik, D. Wolf, and C. J. Binder. 2022. Soluble TREM2 levels reflect the recruitment and expansion of TREM2\u2009+\u2009macrophages that localize to fibrotic areas and limit NASH. Journal Of Hepatology 77(5):1373\u20131385. https:\/\/doi.org\/10.1016\/j.jhep.2022.06.004","journal-title":"Journal Of Hepatology"},{"issue":"10","key":"2545_CR220","doi-asserted-by":"publisher","first-page":"9447","DOI":"10.1007\/s13277-014-2407-x","volume":"35","author":"A Korniluk","year":"2014","unstructured":"Korniluk, A., H. Kemona, and V. Dymicka-Piekarska. 2014. Multifunctional CD40L: pro- and anti-neoplastic activity. Tumour Biology 35(10):9447\u20139457. https:\/\/doi.org\/10.1007\/s13277-014-2407-x","journal-title":"Tumour Biology"},{"key":"2545_CR221","doi-asserted-by":"publisher","first-page":"825892","DOI":"10.3389\/fimmu.2022.825892","volume":"13","author":"F Cognasse","year":"2022","unstructured":"Cognasse, F., A. C. Duchez, E. Audoux, T. Ebermeyer, C. A. Arthaud, A. Prier, M. A. Eyraud, P. Mismetti, O. Garraud, L. Bertoletti, and H. Hamzeh-Cognasse. 2022. Platelets as Key Factors in Inflammation: Focus on CD40L\/CD40. Frontiers In Immunology 13:825892. https:\/\/doi.org\/10.3389\/fimmu.2022.825892","journal-title":"Frontiers In Immunology"},{"issue":"1","key":"2545_CR222","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta, R., M. J. Benson, V. C. de Vries, A. Wasiuk, Y. Guo, and R. J. Noelle. 2009. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunological Reviews 229(1):152\u2013172. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00782.x","journal-title":"Immunological Reviews"},{"issue":"11","key":"2545_CR223","doi-asserted-by":"publisher","first-page":"6812","DOI":"10.4049\/jimmunol.166.11.6812","volume":"166","author":"RF Schwabe","year":"2001","unstructured":"Schwabe, R. F., B. Schnabl, Y. O. Kweon, and D. A. Brenner. 2001. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. The Journal Of Immunology 166(11):6812\u20136819. https:\/\/doi.org\/10.4049\/jimmunol.166.11.6812","journal-title":"The Journal Of Immunology"},{"issue":"8","key":"2545_CR224","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/biomedicines9080863","volume":"9","author":"O Raabe","year":"2021","unstructured":"Raabe, O., T. Birchler, H. Rehrauer, and E. Eppler. 2021. CD40 Agonist Monoclonal Antibody-Mediated Hepatitis in TNF-Receptor 1 Gene Knockout Mice. Biomedicines 9(8):863. https:\/\/doi.org\/10.3390\/biomedicines9080863","journal-title":"Biomedicines"},{"key":"2545_CR225","doi-asserted-by":"publisher","first-page":"107709","DOI":"10.1016\/j.pharmthera.2020.107709","volume":"219","author":"T Tang","year":"2021","unstructured":"Tang, T., X. Cheng, B. Truong, L. Sun, X. Yang, and H. Wang. 2021. Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint. Pharmacology & Therapeutics 219:107709. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107709","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"2545_CR226","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/hep.21274","volume":"44","author":"V Schmitz","year":"2006","unstructured":"Schmitz, V., F. Dombrowski, J. Prieto, C. Qian, L. Diehl, P. Knolle, T. Sauerbruch, W. H. Caselmann, U. Spengler, and L. Leifeld. 2006. Induction of murine liver damage by overexpression of CD40 ligand provides an experimental model to study fulminant hepatic failure. Hepatology 44(2):430\u2013439. https:\/\/doi.org\/10.1002\/hep.21274","journal-title":"Hepatology"},{"issue":"10","key":"2545_CR227","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1161\/ATVBAHA.111.231357","volume":"31","author":"M Poggi","year":"2011","unstructured":"Poggi, M., D. Engel, A. Christ, L. Beckers, E. Wijnands, L. Boon, A. Driessen, J. Cleutjens, C. Weber, N. Gerdes, and E. Lutgens. 2011. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice. Arteriosclerosis, Thrombosis, And Vascular Biology 31(10):2251\u20132260. https:\/\/doi.org\/10.1161\/ATVBAHA.111.231357","journal-title":"Arteriosclerosis, Thrombosis, And Vascular Biology"},{"issue":"2","key":"2545_CR228","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/cvr\/cvx197","volume":"114","author":"S Steven","year":"2018","unstructured":"Steven, S., M. Dib, M. Hausding, F. Kashani, M. Oelze, S. Kr\u00f6ller-Sch\u00f6n, A. Hanf, S. Daub, S. Roohani, Y. Gramlich, E. Lutgens, E. Schulz, C. Becker, K. J. Lackner, H. Kleinert, C. Knosalla, B. Niesler, P. S. Wild, T. M\u00fcnzel, and A. Daiber. 2018. CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db\/db mice. Cardiovasc Res 114(2):312\u2013323. https:\/\/doi.org\/10.1093\/cvr\/cvx197","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2545_CR229","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2006.04.001","volume":"106","author":"T Fujita","year":"2006","unstructured":"Fujita, T., N. Ukyo, T. Hori, and T. Uchiyama. 2006. Functional characterization of OX40 expressed on human CD8\u2009+\u2009T cells. Immunology Letters 106(1):27\u201333. https:\/\/doi.org\/10.1016\/j.imlet.2006.04.001","journal-title":"Immunology Letters"},{"issue":"4","key":"2545_CR230","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/1744666X.2023.2294046","volume":"20","author":"J Schw\u00e4rzler","year":"2024","unstructured":"Schw\u00e4rzler, J., F. Grabherr, C. Grander, T. E. Adolph, and H. Tilg. 2024. The pathophysiology of MASLD: an immunometabolic perspective. Expert Review Of Clinical Immunology 20(4):375\u2013386. https:\/\/doi.org\/10.1080\/1744666X.2023.2294046","journal-title":"Expert Review Of Clinical Immunology"},{"issue":"3","key":"2545_CR231","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.immuni.2020.08.013","volume":"53","author":"AH Lee","year":"2020","unstructured":"Lee, A. H., and V. D. Dixit. 2020. Dietary Regulation of Immunity. Immunity 53(3):510\u2013523. https:\/\/doi.org\/10.1016\/j.immuni.2020.08.013","journal-title":"Immunity"},{"key":"2545_CR232","doi-asserted-by":"publisher","unstructured":"Nemer, M., F. Osman, and A. Said. 2024. Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database. Annals Of Hepatology 29(3):101491. https:\/\/doi.org\/10.1016\/j.aohep.2024.101491","DOI":"10.1016\/j.aohep.2024.101491"},{"issue":"1","key":"2545_CR233","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu, T., C. H. Liu, M. Lei, Q. Zeng, L. Li, H. Tang, and N. Zhang. 2024. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct Target Ther 9(1):268. https:\/\/doi.org\/10.1038\/s41392-024-01954-6","journal-title":"Signal Transduct Target Ther"},{"issue":"15","key":"2545_CR234","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.3390\/cells12151930","volume":"12","author":"H Qu","year":"2023","unstructured":"Qu, H., J. Liu, D. Zhang, R. Xie, L. Wang, and J. Hong. 2023. Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic Opportunities. Cells 12(15):1930. https:\/\/doi.org\/10.3390\/cells12151930","journal-title":"Cells"},{"key":"2545_CR235","doi-asserted-by":"publisher","first-page":"107990","DOI":"10.1016\/j.phrs.2025.107990","volume":"221","author":"Y Shang","year":"2025","unstructured":"Shang, Y., Q. Sun, X. Xin, Z. Wang, S. Gao, R. Lin, Y. Hu, X. Wang, and Q. Feng. 2025. The role of glycolysis in MASLD development: Pathogenesis and therapeutic strategies. Pharmacological Research 221:107990. https:\/\/doi.org\/10.1016\/j.phrs.2025.107990","journal-title":"Pharmacological Research"},{"key":"2545_CR236","doi-asserted-by":"publisher","first-page":"920029","DOI":"10.3389\/fimmu.2022.920029","volume":"13","author":"Y Xu","year":"2022","unstructured":"Xu, Y., Y. Chen, X. Zhang, J. Ma, Y. Liu, L. Cui, and F. Wang. 2022. Glycolysis in Innate Immune Cells Contributes to Autoimmunity. Frontiers In Immunology 13:920029. https:\/\/doi.org\/10.3389\/fimmu.2022.920029","journal-title":"Frontiers In Immunology"},{"issue":"2","key":"2545_CR237","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/imm.12437","volume":"145","author":"O Rodr\u00edguez-Espinosa","year":"2015","unstructured":"Rodr\u00edguez-Espinosa, O., O. Rojas-Espinosa, M. M. Moreno-Altamirano, E. O. L\u00f3pez-Villegas, and F. J. S\u00e1nchez-Garc\u00eda. 2015. Metabolic requirements for neutrophil extracellular traps formation. Immunology 145(2):213\u2013224. https:\/\/doi.org\/10.1111\/imm.12437","journal-title":"Immunology"},{"issue":"12","key":"2545_CR238","doi-asserted-by":"publisher","first-page":"165542","DOI":"10.1016\/j.bbadis.2019.165542","volume":"1865","author":"D Awasthi","year":"2019","unstructured":"Awasthi, D., S. Nagarkoti, S. Sadaf, T. Chandra, S. Kumar, and M. Dikshit. 2019. Glycolysis dependent lactate formation in neutrophils: A metabolic link between NOX-dependent and independent NETosis. Biochim Biophys Acta Mol Basis Dis 1865(12):165542. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165542","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"2545_CR239","doi-asserted-by":"publisher","first-page":"115350","DOI":"10.1016\/j.celrep.2025.115350","volume":"44","author":"J Li","year":"2025","unstructured":"Li, J., X. Chen, S. Song, W. Jiang, T. Geng, T. Wang, Y. Xu, Y. Zhu, J. Lu, Y. Xia, and R. Wang. 2025. Hexokinase 2-mediated metabolic stress and inflammation burden of liver macrophages via histone lactylation in MASLD. Cell Rep 44(3):115350. https:\/\/doi.org\/10.1016\/j.celrep.2025.115350","journal-title":"Cell Rep"},{"issue":"4","key":"2545_CR240","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ni.2833","volume":"15","author":"B Everts","year":"2014","unstructured":"Everts, B., E. Amiel, S. C. Huang, A. M. Smith, C. H. Chang, W. Y. Lam, V. Redmann, T. C. Freitas, J. Blagih, G. J. van der Windt, M. N. Artyomov, R. G. Jones, E. L. Pearce, and E. J. Pearce. 2014. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK\u025b supports the anabolic demands of dendritic cell activation. Nature Immunology 15(4):323\u2013332. https:\/\/doi.org\/10.1038\/ni.2833","journal-title":"Nature Immunology"},{"issue":"12","key":"2545_CR241","doi-asserted-by":"publisher","first-page":"e127395","DOI":"10.1172\/jci.insight.127395","volume":"4","author":"M Kono","year":"2019","unstructured":"Kono, M., K. Maeda, I. Stocton-Gavanescu, W. Pan, M. Umeda, E. Katsuyama, C. Burbano, S. Y. K. Orite, M. Vukelic, M. G. Tsokos, N. Yoshida, and G. C. Tsokos. 2019. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation. JCI Insight 4(12):e127395. https:\/\/doi.org\/10.1172\/jci.insight.127395","journal-title":"JCI Insight"},{"issue":"6","key":"2545_CR242","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cmet.2021.04.018","volume":"33","author":"ME Moreno-Fernandez","year":"2021","unstructured":"Moreno-Fernandez, M. E., D. A. Giles, J. R. Oates, C. C. Chan, M. S. M. A. Damen, J. R. Doll, T. E. Stankiewicz, X. Chen, K. Chetal, R. Karns, M. T. Weirauch, L. Romick-Rosendale, S. A. Xanthakos, R. Sheridan, S. Szabo, A. S. Shah, M. A. Helmrath, T. H. Inge, H. Deshmukh, N. Salomonis, and S. Divanovic. 2021. PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. Cell Metab 33(6):1187\u20131204e9. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.018","journal-title":"Cell Metab"},{"key":"2545_CR243","doi-asserted-by":"publisher","first-page":"1420336","DOI":"10.3389\/fimmu.2024.1420336","volume":"15","author":"F Kemp","year":"2024","unstructured":"Kemp, F., E. L. Braverman, and C. A. Byersdorfer. 2024. Fatty acid oxidation in immune function. Frontiers In Immunology 15:1420336. https:\/\/doi.org\/10.3389\/fimmu.2024.1420336","journal-title":"Frontiers In Immunology"},{"issue":"11","key":"2545_CR244","doi-asserted-by":"publisher","first-page":"e2319254121","DOI":"10.1073\/pnas.2319254121","volume":"121","author":"S Sheppard","year":"2024","unstructured":"Sheppard, S., K. Srpan, W. Lin, M. Lee, R. B. Delconte, M. Owyong, P. Carmeliet, D. M. Davis, J. B. Xavier, K. C. Hsu, and J. C. Sun. 2024. Fatty acid oxidation fuels natural killer cell responses against infection and cancer. Proc Natl Acad Sci U S A 121(11):e2319254121. https:\/\/doi.org\/10.1073\/pnas.2319254121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2545_CR245","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","volume":"19","author":"X Michelet","year":"2018","unstructured":"Michelet, X., L. Dyck, A. Hogan, R. M. Loftus, D. Duquette, K. Wei, S. Beyaz, A. Tavakkoli, C. Foley, R. Donnelly, C. O\u2019Farrelly, M. Raverdeau, A. Vernon, W. Pettee, D. O\u2019Shea, B. S. Nikolajczyk, K. H. G. Mills, M. B. Brenner, D. Finlay, and L. Lynch. 2018. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nature Immunology 19(12):1330\u20131340. https:\/\/doi.org\/10.1038\/s41590-018-0251-7","journal-title":"Nature Immunology"},{"issue":"26","key":"2545_CR246","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1182\/blood.2020005602","volume":"136","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T., P. Y. Lam, H. Jiang, K. Bednarska, R. Gloury, V. Murigneux, J. Tay, N. Jacquelot, R. Li, Z. K. Tuong, G. R. Leggatt, M. K. Gandhi, M. M. Hill, G. T. Belz, S. Ngo, A. Kallies, and S. R. Mattarollo. 2020. Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood 136(26):3004\u20133017. https:\/\/doi.org\/10.1182\/blood.2020005602","journal-title":"Blood"},{"issue":"9","key":"2545_CR247","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.4049\/jimmunol.174.9.5390","volume":"174","author":"AR Weatherill","year":"2005","unstructured":"Weatherill, A. R., J. Y. Lee, L. Zhao, D. G. Lemay, H. S. Youn, and D. H. Hwang. 2005. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. The Journal Of Immunology 174(9):5390\u20135397. https:\/\/doi.org\/10.4049\/jimmunol.174.9.5390","journal-title":"The Journal Of Immunology"},{"issue":"7","key":"2545_CR248","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"JR Cubillos-Ruiz","year":"2015","unstructured":"Cubillos-Ruiz, J. R., P. C. Silberman, M. R. Rutkowski, S. Chopra, A. Perales-Puchalt, M. Song, S. Zhang, S. E. Bettigole, D. Gupta, K. Holcomb, L. H. Ellenson, T. Caputo, A. H. Lee, J. R. Conejo-Garcia, and L. H. Glimcher. 2015. ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis. Cell 161(7):1527\u20131538. https:\/\/doi.org\/10.1016\/j.cell.2015.05.025","journal-title":"Cell"},{"issue":"8","key":"2545_CR249","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.2172","volume":"16","author":"DL Herber","year":"2010","unstructured":"Herber, D. L., W. Cao, Y. Nefedova, S. V. Novitskiy, S. Nagaraj, V. A. Tyurin, A. Corzo, H. I. Cho, E. Celis, B. Lennox, S. C. Knight, T. Padhya, T. V. McCaffrey, J. C. McCaffrey, S. Antonia, M. Fishman, R. L. Ferris, V. E. Kagan, and D. I. Gabrilovich. 2010. Lipid accumulation and dendritic cell dysfunction in cancer. Nature Medicine 16(8):880\u2013886. https:\/\/doi.org\/10.1038\/nm.2172","journal-title":"Nature Medicine"},{"issue":"6","key":"2545_CR250","doi-asserted-by":"publisher","first-page":"e002548","DOI":"10.1136\/jitc-2021-002548","volume":"9","author":"S Liu","year":"2021","unstructured":"Liu, S., H. Zhang, Y. Li, Y. Zhang, Y. Bian, Y. Zeng, X. Yao, J. Wan, X. Chen, J. Li, Z. Wang, and Z. Qin. 2021. S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation. Journal For Immunotherapy Of Cancer 9(6):e002548. https:\/\/doi.org\/10.1136\/jitc-2021-002548","journal-title":"Journal For Immunotherapy Of Cancer"},{"key":"2545_CR251","doi-asserted-by":"publisher","first-page":"e80721","DOI":"10.7554\/eLife.80721","volume":"12","author":"RE Menjivar","year":"2023","unstructured":"Menjivar, R. E., Z. C. Nwosu, W. Du, K. L. Donahue, H. S. Hong, C. Espinoza, K. Brown, A. Velez-Delgado, W. Yan, F. Lima, A. Bischoff, P. Kadiyala, D. Salas-Escabillas, H. C. Crawford, F. Bednar, E. Carpenter, Y. Zhang, C. J. Halbrook, and C. A. Lyssiotis. 2023. Pasca di Magliano M. Arginase 1 is a key driver of immune suppression in pancreatic cancer. Elife 12:e80721. https:\/\/doi.org\/10.7554\/eLife.80721","journal-title":"Elife"},{"issue":"1","key":"2545_CR252","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","volume":"36","author":"GJ van der Windt","year":"2012","unstructured":"van der Windt, G. J., B. Everts, C. H. Chang, J. D. Curtis, T. C. Freitas, E. Amiel, E. J. Pearce, and E. L. Pearce. 2012. Mitochondrial respiratory capacity is a critical regulator of CD8\u2009+\u2009T cell memory development. Immunity 36(1):68\u201378. https:\/\/doi.org\/10.1016\/j.immuni.2011.12.007","journal-title":"Immunity"},{"issue":"4","key":"2545_CR253","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cmet.2023.02.013","volume":"35","author":"CB Nava Lauson","year":"2023","unstructured":"Nava Lauson, C. B., S. Tiberti, P. A. Corsetto, F. Conte, P. Tyagi, M. Machwirth, S. Ebert, A. Loffreda, L. Scheller, D. Sheta, Z. Mokhtari, T. Peters, A. T. Raman, F. Greco, A. M. Rizzo, A. Beilhack, G. Signore, N. Tumino, P. Vacca, L. A. McDonnell, A. Raimondi, P. D. Greenberg, J. B. Huppa, S. Cardaci, I. Caruana, S. Rodighiero, L. Nezi, and T. Manzo. 2023. Linoleic acid potentiates CD8\u2009+\u2009T cell metabolic fitness and antitumor immunity. Cell Metab 35(4):633\u2013650e9. https:\/\/doi.org\/10.1016\/j.cmet.2023.02.013","journal-title":"Cell Metab"},{"issue":"3","key":"2545_CR254","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","volume":"21","author":"FJ Weisel","year":"2020","unstructured":"Weisel, F. J., S. J. Mullett, R. A. Elsner, A. V. Menk, N. Trivedi, W. Luo, D. Wikenheiser, W. F. Hawse, M. Chikina, S. Smita, L. J. Conter, S. M. Joachim, S. G. Wendell, M. J. Jurczak, T. H. Winkler, G. M. Delgoffe, and M. J. Shlomchik. 2020. Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nature Immunology 21(3):331\u2013342. https:\/\/doi.org\/10.1038\/s41590-020-0598-4","journal-title":"Nature Immunology"},{"issue":"7628","key":"2545_CR255","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nature20117","volume":"539","author":"X Wei","year":"2016","unstructured":"Wei, X., H. Song, L. Yin, M. G. Rizzo, R. Sidhu, D. F. Covey, D. S. Ory, and C. F. Semenkovich. 2016. Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. Nature 539(7628):294\u2013298. https:\/\/doi.org\/10.1038\/nature20117","journal-title":"Nature"},{"issue":"2","key":"2545_CR256","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cmet.2016.11.009","volume":"25","author":"Y Oishi","year":"2017","unstructured":"Oishi, Y., N. J. Spann, V. M. Link, E. D. Muse, T. Strid, C. Edillor, M. J. Kolar, T. Matsuzaka, S. Hayakawa, J. Tao, M. U. Kaikkonen, A. F. Carlin, M. T. Lam, I. Manabe, H. Shimano, A. Saghatelian, and C. K. Glass. 2017. SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism. Cell Metab 25(2):412\u2013427. https:\/\/doi.org\/10.1016\/j.cmet.2016.11.009","journal-title":"Cell Metab"},{"issue":"9","key":"2545_CR257","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu, P. S., H. Wang, X. Li, T. Chao, T. Teav, S. Christen, G. Di Conza, W. C. Cheng, C. H. Chou, M. Vavakova, C. Muret, K. Debackere, M. Mazzone, H. D. Huang, S. M. Fendt, J. Ivanisevic, and P. C. Ho. 2017. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nature Immunology 18(9):985\u2013994.","journal-title":"Nature Immunology"},{"issue":"1","key":"2545_CR258","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13045-023-01453-1","volume":"16","author":"L Yang","year":"2023","unstructured":"Yang, L., Z. Chu, M. Liu, Q. Zou, J. Li, Q. Liu, Y. Wang, T. Wang, J. Xiang, and B. Wang. 2023. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy. Journal Of Hematology & Oncology 16(1):59. https:\/\/doi.org\/10.1186\/s13045-023-01453-1","journal-title":"Journal Of Hematology & Oncology"},{"issue":"3","key":"2545_CR259","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3350\/cmh.2025.0048","volume":"31","author":"E Kakazu","year":"2025","unstructured":"Kakazu, E., M. Mino, and T. Kanto. 2025. Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease. Clin Mol Hepatol 31(3):771\u2013795. https:\/\/doi.org\/10.3350\/cmh.2025.0048","journal-title":"Clin Mol Hepatol"},{"issue":"Suppl 2","key":"2545_CR260","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12072-024-10663-9","volume":"18","author":"SE Keating","year":"2024","unstructured":"Keating, S. E., Y. Chawla, A. De, and E. S. George. 2024. Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective. Hepatol Int 18(Suppl 2):959\u2013976. https:\/\/doi.org\/10.1007\/s12072-024-10663-9","journal-title":"Hepatol Int"},{"issue":"3","key":"2545_CR261","doi-asserted-by":"publisher","first-page":"G329","DOI":"10.1152\/ajpgi.00044.2018","volume":"315","author":"S Hohenester","year":"2018","unstructured":"Hohenester, S., S. Christiansen, J. Nagel, R. Wimmer, R. Artmann, G. Denk, M. Bischoff, G. Bischoff, and C. Rust. 2018. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis. American Journal Of Physiology. Gastrointestinal And Liver Physiology 315(3):G329\u2013G338. https:\/\/doi.org\/10.1152\/ajpgi.00044.2018","journal-title":"American Journal Of Physiology. Gastrointestinal And Liver Physiology"},{"issue":"6","key":"2545_CR262","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/ijerph21060708","volume":"21","author":"J Niu","year":"2024","unstructured":"Niu, J., W. Al-Yaman, K. Pinyopornpanish, J. S. Park, M. Salazar, H. Xiao, J. Bena, R. Lyu, G. Flocco, S. R. Junna, T. Adhami, O. T. Sims, and J. Wakim-Fleming. 2024. The Long-Term Effect of Weight Loss on the Prevention of Progression to Cirrhosis among Patients with Obesity and MASH-Related F3 Liver Fibrosis. International Journal Of Environmental Research And Public Health 21(6):708. https:\/\/doi.org\/10.3390\/ijerph21060708","journal-title":"International Journal Of Environmental Research And Public Health"},{"key":"2545_CR263","doi-asserted-by":"publisher","first-page":"1518687","DOI":"10.3389\/fimmu.2025.1518687","volume":"16","author":"A Provera","year":"2025","unstructured":"Provera, A., N. N. Ramavath, L. L. Gadipudi, C. Vecchio, M. Caputo, A. Antonioli, S. Tini, A. N. Sheferaw, S. Reano, N. Filigheddu, M. Manfredi, E. Barberis, L. Cocolin, I. Ferrocino, M. Locatelli, M. Caprio, F. Tacke, E. Albano, F. Prodam, and S. Sutti. 2025. Vegetal oil-based ketogenic diet improves inflammation and fibrosis in experimental metabolic dysfunction-associated steatohepatitis. Frontiers In Immunology 16:1518687. https:\/\/doi.org\/10.3389\/fimmu.2025.1518687","journal-title":"Frontiers In Immunology"},{"key":"2545_CR264","doi-asserted-by":"publisher","unstructured":"Mooli, R. G. R., Y. Han, E. J. Fiorenza, K. Balakrishnan, J. S. Kanshana, S. Kumar, F. M. Bello, A. R. Nallanagulagari, S. Karra, J. Tao, E. R. Delgado, L. Teng, A. B. Kohan, A. D. Singhi, M. Jurczak, and S. K. Ramakrishnan. 2025. Hepatic ketogenesis regulates lipid homeostasis Via ACSL1-mediated fatty acid partitioning. Cellular and Molecular Gastroenterology and Hepatology 19:101593. https:\/\/doi.org\/10.1016\/j.jcmgh.2025.101593","DOI":"10.1016\/j.jcmgh.2025.101593"},{"issue":"6","key":"2545_CR265","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.clnu.2024.04.029","volume":"43","author":"Y You","year":"2024","unstructured":"You, Y., Y. Huang, X. Wang, H. Ni, Q. Ma, H. Ran, J. Cai, X. Lin, T. Luo, C. Wu, X. Xiao, and L. Ma. 2024. Ketogenic diet time-dependently prevents NAFLD through upregulating the expression of antioxidant protein metallothionein-2. Clinical Nutrition 43(6):1475\u20131487. https:\/\/doi.org\/10.1016\/j.clnu.2024.04.029","journal-title":"Clinical Nutrition"},{"issue":"6","key":"2545_CR266","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/14656566.2025.2478917","volume":"26","author":"S Bhushan","year":"2025","unstructured":"Bhushan, S., A. Sohal, M. Noureddin, and K. V. Kowdley. 2025. Resmetirom: the first approved therapy for treating metabolic dysfunction associated steatohepatitis. Expert Opinion On Pharmacotherapy 26(6):663\u2013675. https:\/\/doi.org\/10.1080\/14656566.2025.2478917","journal-title":"Expert Opinion On Pharmacotherapy"},{"issue":"12","key":"2545_CR267","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome, P. N., K. Buchholtz, K. Cusi, M. Linder, T. Okanoue, V. Ratziu, A. J. Sanyal, A. S. Sejling, and S. A. Harrison. 2021. NN9931-4296 Investigators. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. New England Journal Of Medicine 384(12):1113\u20131124. https:\/\/doi.org\/10.1056\/NEJMoa2028395","journal-title":"New England Journal Of Medicine"},{"key":"2545_CR268","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijtm5010007","volume":"5","author":"S Dinerman","year":"2025","unstructured":"Dinerman, S., and Y. Shu. 2025. Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials. Int J Transl Med 5:7. https:\/\/doi.org\/10.3390\/ijtm5010007","journal-title":"Int J Transl Med"},{"key":"2545_CR269","doi-asserted-by":"publisher","first-page":"101320","DOI":"10.1016\/j.lanepe.2025.101320","volume":"54","author":"JV Lazarus","year":"2025","unstructured":"Lazarus, J. V., P. N. Brennan, H. E. Mark, W. Alazawi, A. M. Allen, C. D. Byrne, L. Castera, C. Caussy, K. Cusi, M. M. Grajower, C. J. Kopka, J. Massoels, M. Roden, C. W. Spearman, F. Tacke, V. W. Wong, and M. Noureddin. 2025. A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis. Lancet Reg Health Eur 54:101320. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101320","journal-title":"Lancet Reg Health Eur"},{"issue":"15","key":"2545_CR270","doi-asserted-by":"publisher","first-page":"e35338","DOI":"10.1016\/j.heliyon.2024.e35338","volume":"10","author":"A Provera","year":"2024","unstructured":"Provera, A., C. Vecchio, A. N. Sheferaw, I. Stoppa, D. Pantham, U. Dianzani, and S. Sutti. 2024. From MASLD to HCC: What\u2019s in the middle? Heliyon 10(15):e35338. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35338","journal-title":"Heliyon"},{"issue":"1","key":"2545_CR271","doi-asserted-by":"publisher","first-page":"BSR20221271","DOI":"10.1042\/BSR20221271","volume":"43","author":"S Cannito","year":"2023","unstructured":"Cannito, S., U. Dianzani, M. Parola, E. Albano, and S. Sutti. 2023. Inflammatory processes involved in NASH-related hepatocellular carcinoma. Bioscience Reports 43(1):BSR20221271. https:\/\/doi.org\/10.1042\/BSR20221271","journal-title":"Bioscience Reports"},{"issue":"2","key":"2545_CR272","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jcmgh.2021.10.002","volume":"13","author":"B Foglia","year":"2022","unstructured":"Foglia, B., S. Sutti, S. Cannito, C. Rosso, M. Maggiora, R. Autelli, E. Novo, C. Bocca, G. Villano, N. N. Ramavath, R. Younes, I. Tusa, E. Rovida, P. Pontisso, E. Bugianesi, E. Albano, and M. Parola. 2022. Hepatocyte-Specific Deletion of HIF2\u03b1 Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation. Cell Mol Gastroenterol Hepatol 13(2):459\u2013482. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.10.002","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"2545_CR273","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/13543784.2018.1442436","volume":"27","author":"F Tacke","year":"2018","unstructured":"Tacke, F. 2018. Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis. Expert Opinion On Investigational Drugs 27(3):301\u2013311. https:\/\/doi.org\/10.1080\/13543784.2018.1442436","journal-title":"Expert Opinion On Investigational Drugs"},{"issue":"1","key":"2545_CR274","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","volume":"22","author":"QM Anstee","year":"2024","unstructured":"Anstee, Q. M., B. A. Neuschwander-Tetri, V. Wai-Sun Wong, M. F. Abdelmalek, G. Rodriguez-Araujo, H. Landgren, G. S. Park, P. Bedossa, N. Alkhouri, F. Tacke, and A. J. Sanyal. 2024. Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study. Clinical Gastroenterology And Hepatology 22(1):124\u2013134e1. https:\/\/doi.org\/10.1016\/j.cgh.2023.04.003","journal-title":"Clinical Gastroenterology And Hepatology"},{"key":"2545_CR275","doi-asserted-by":"publisher","first-page":"119052","DOI":"10.1016\/j.biopha.2026.119052","volume":"195","author":"\u00c1 Berlana","year":"2026","unstructured":"Berlana, \u00c1, E. Rey, E. Fresno-Ventura, P. Gomez-Gutierrez, M. Vega, C. Garc\u00eda-Monz\u00f3n, and \u00c1 Gonz\u00e1lez-Rodr\u00edguez. 2026. The inhibition of Il1\u03b2 synthesis mediated by a novel pyridine-sulfonamide compound protects against the progression of metabolic dysfunction-associated steatotic liver disease. Biomedicine & Pharmacotherapy 195:119052. https:\/\/doi.org\/10.1016\/j.biopha.2026.119052","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2545_CR276","doi-asserted-by":"publisher","first-page":"102870","DOI":"10.1016\/j.redox.2023.102870","volume":"66","author":"K Burger","year":"2023","unstructured":"Burger, K., F. Jung, A. Baumann, A. Brandt, R. Staltner, V. S\u00e1nchez, and I. Bergheim. 2023. TNF\u03b1 is a key trigger of inflammation in diet-induced non-obese MASLD in mice. Redox Biology 66:102870. https:\/\/doi.org\/10.1016\/j.redox.2023.102870","journal-title":"Redox Biology"},{"key":"2545_CR277","doi-asserted-by":"publisher","first-page":"105922","DOI":"10.1016\/j.cct.2019.105922","volume":"89","author":"QM Anstee","year":"2020","unstructured":"Anstee, Q. M., B. A. Neuschwander-Tetri, V. W. Wong, M. F. Abdelmalek, Z. M. Younossi, J. Yuan, M. L. Pecoraro, S. Seyedkazemi, L. Fischer, P. Bedossa, Z. Goodman, N. Alkhouri, F. Tacke, and A. Sanyal. 2020. Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design. Contemporary Clinical Trials 89:105922. https:\/\/doi.org\/10.1016\/j.cct.2019.105922","journal-title":"Contemporary Clinical Trials"},{"issue":"4","key":"2545_CR278","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1055\/s-0041-1730926","volume":"41","author":"N Li","year":"2021","unstructured":"Li, N., G. Yamamoto, H. Fuji, and T. Kisseleva. 2021. Interleukin-17 in Liver Disease Pathogenesis. Seminars In Liver Disease 41(4):507\u2013515. https:\/\/doi.org\/10.1055\/s-0041-1730926","journal-title":"Seminars In Liver Disease"},{"issue":"1","key":"2545_CR279","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.5826\/dpc.1601a6746","volume":"16","author":"U Bakay","year":"2026","unstructured":"Bakay, U., T. I. Duran, O. S. K. Bakay, and R. Ekmekcioglu. 2026. Hepatic Safety of IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis: A 12-Month Retrospective Cohort Evaluation Using the FIB-4 Index. Dermatol Pract Concept 16(1):6746. https:\/\/doi.org\/10.5826\/dpc.1601a6746","journal-title":"Dermatol Pract Concept"},{"key":"2545_CR280","doi-asserted-by":"publisher","first-page":"175628482513358","DOI":"10.1177\/17562848251335824","volume":"18","author":"J Gonz\u00e1lez Fern\u00e1ndez","year":"2025","unstructured":"Gonz\u00e1lez Fern\u00e1ndez, J., L. Prieto-Torres, M. Ara Mart\u00edn, and S. J. Mart\u00ednez-Dom\u00ednguez. 2025. MASLD and liver fibrosis in patients with psoriasis receiving IL-17 or IL-23 inhibitors: a systematic review. Ther Adv Gastroenterol 18:17562848251335824. https:\/\/doi.org\/10.1177\/17562848251335824","journal-title":"Ther Adv Gastroenterol"},{"key":"2545_CR281","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen, C., Z. Wang, Y. Ding, and Y. Qin. 2023. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Frontiers In Immunology 14:1133308. https:\/\/doi.org\/10.3389\/fimmu.2023.1133308","journal-title":"Frontiers In Immunology"},{"issue":"8","key":"2545_CR282","doi-asserted-by":"publisher","first-page":"101421","DOI":"10.1016\/j.jhepr.2025.101421","volume":"7","author":"RF Schwabe","year":"2025","unstructured":"Schwabe, R. F., F. Tacke, A. Sugimoto, and S. L. Friedman. 2025. Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease. JHEP Rep 7(8):101421. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101421","journal-title":"JHEP Rep"},{"key":"2545_CR283","doi-asserted-by":"publisher","unstructured":"Valenzuela-P\u00e9rez, L., H. S. Kim Lee, R. L. Bayer, S. K. Mishra, A. M. Washington, Q. Guo, A. Herman, R. P. Graham, M. M. Sidahmed, E. Ssali, A. A. Hassan, E. J. Dinc, K. D. Pavelko, G. J. Gores, P. Starlinger, X. S. Revelo, S. H. Ibrahim, E. Kostallari, A. O. Bamidele, and P. Hirsova. 2025. CD4\u2009+\u2009T cells promote fibrosis during metabolic dysfunction-associated steatohepatitis. bioRxiv [Preprint]. 3:2025.06.27.660220. https:\/\/doi.org\/10.1101\/2025.06.27.660220","DOI":"10.1101\/2025.06.27.660220"},{"issue":"13","key":"2545_CR284","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.4254\/wjh.v7.i13.1725","volume":"7","author":"S Sutti","year":"2015","unstructured":"Sutti, S., A. Jindal, S. Bruzz\u00ec, I. Locatelli, C. Bozzola, and E. Albano. 2015. Is there a role for adaptive immunity in nonalcoholic steatohepatitis? World Journal Of Hepatology 7(13):1725\u20131729. https:\/\/doi.org\/10.4254\/wjh.v7.i13.1725","journal-title":"World Journal Of Hepatology"},{"key":"2545_CR285","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.redox.2020.101634","volume":"36","author":"F Xu","year":"2020","unstructured":"Xu, F., M. Guo, W. Huang, L. Feng, J. Zhu, K. Luo, J. Gao, B. Zheng, L. D. Kong, T. Pang, X. Wu, and Q. Xu. 2020. Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. Redox Biology 36:101634. https:\/\/doi.org\/10.1016\/j.redox.2020.101634","journal-title":"Redox Biology"},{"issue":"1","key":"2545_CR286","doi-asserted-by":"publisher","first-page":"108614","DOI":"10.1016\/j.isci.2023.108614","volume":"27","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Z. Liu, X. Yin, E. Wang, and J. Wang. 2023. NSC48160 targets AMPK\u03b1 to ameliorate nonalcoholic steatohepatitis by inhibiting lipogenesis and mitochondrial oxidative stress. iScience 27(1):108614. https:\/\/doi.org\/10.1016\/j.isci.2023.108614","journal-title":"iScience"},{"key":"2545_CR287","doi-asserted-by":"publisher","first-page":"115447","DOI":"10.1016\/j.biopha.2023.115447","volume":"167","author":"M Arora","year":"2023","unstructured":"Arora, M., Z. Pavl\u00edkov\u00e1, T. Ku\u010dera, P. Kozl\u00edk, T. \u0160opin, T. Vac\u00edk, M. \u013dupt\u00e1k, M. Duda, and O. Slana\u0159. 2023. Kutinov\u00e1 Canov\u00e1 N. Pharmacological effects of mTORC1\/C2 inhibitor in a preclinical model of NASH progression. Biomedicine & Pharmacotherapy 167:115447. https:\/\/doi.org\/10.1016\/j.biopha.2023.115447","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6","key":"2545_CR288","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G., J. Dom\u00ednguez-Andr\u00e9s, L. B. Barreiro, T. Chavakis, M. Divangahi, E. Fuchs, L. A. B. Joosten, J. W. M. van der Meer, M. M. Mhlanga, W. J. M. Mulder, N. P. Riksen, A. Schlitzer, J. L. Schultze, C. Stabell Benn, J. C. Sun, R. J. Xavier, and E. Latz. 2020. Defining trained immunity and its role in health and disease. Nature Reviews Immunology 20(6):375\u2013388. https:\/\/doi.org\/10.1038\/s41577-020-0285-6. Epub 2020 Mar 4. PMID: 32132681; PMCID: PMC7186935.","journal-title":"Nature Reviews Immunology"},{"key":"2545_CR289","doi-asserted-by":"publisher","unstructured":"Sun, S. J., R. Aguirre-Gamboa, and L. B. Barreiro. 2026. Molecular and cellular bases of trained immunity. Immunity 59(4):897\u2013910. https:\/\/doi.org\/10.1016\/j.immuni.2026.03.001. PMID: 41985444.","DOI":"10.1016\/j.immuni.2026.03.001"},{"issue":"8","key":"2545_CR290","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3390\/biomedicines13082004","volume":"13","author":"M Romeo","year":"2025","unstructured":"Romeo, M., A. Silvestrin, G. Senese, F. Di Nardo, C. Napolitano, P. Vaia, A. Coppola, P. Federico, M. Dallio, and A. Federico. 2025. From Traditional to Trained Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Biomedicines 13(8):2004. https:\/\/doi.org\/10.3390\/biomedicines13082004. PMID: 40868256; PMCID: PMC12383409.","journal-title":"Biomedicines"},{"issue":"7783","key":"2545_CR291","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran, P., R. Dobie, J. R. Wilson-Kanamori, E. F. Dora, B. E. P. Henderson, N. T. Luu, J. R. Portman, K. P. Matchett, M. Brice, J. A. Marwick, R. S. Taylor, M. Efremova, R. Vento-Tormo, N. O. Carragher, T. J. Kendall, J. A. Fallowfield, E. M. Harrison, D. J. Mole, S. J. Wigmore, P. N. Newsome, C. J. Weston, J. P. Iredale, F. Tacke, J. W. Pollard, C. P. Ponting, J. C. Marioni, S. A. Teichmann, and N. C. Henderson. 2019. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575(7783):512\u2013518. https:\/\/doi.org\/10.1038\/s41586-019-1631-3. Epub 2019 Oct 9. PMID: 31597160; PMCID: PMC6876711.","journal-title":"Nature"},{"issue":"11","key":"2545_CR292","doi-asserted-by":"publisher","first-page":"101196","DOI":"10.1016\/j.jhepr.2024.101196","volume":"6","author":"FF De Ponti","year":"2024","unstructured":"De Ponti, F. F., Z. Liu, and C. L. Scott. 2024. Understanding the complex macrophage landscape in MASLD. JHEP Rep 6(11):101196. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101196. PMID: 39524202; PMCID: PMC11550213.","journal-title":"JHEP Rep"},{"issue":"10","key":"2545_CR293","doi-asserted-by":"publisher","first-page":"113164","DOI":"10.1016\/j.celrep.2023.113164","volume":"42","author":"W Li","year":"2023","unstructured":"Li, W., Y. Yang, L. Yang, N. Chang, and L. Li. 2023. Monocyte-derived Kupffer cells dominate in the Kupffer cell pool during liver injury. Cell Rep 42(10):113164. https:\/\/doi.org\/10.1016\/j.celrep.2023.113164. Epub 2023 Sep 25. PMID: 37740916.","journal-title":"Cell Rep"},{"issue":"12","key":"2545_CR294","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.14218\/JCTH.2024.00317","volume":"12","author":"L Wang","year":"2024","unstructured":"Wang, L., Z. Dong, Y. Zhang, and L. Peng. 2024. Emerging Roles of High-mobility Group Box-1 in Liver Disease. J Clin Transl Hepatol 12(12):1043\u20131056. https:\/\/doi.org\/10.14218\/JCTH.2024.00317. Epub 2024 Oct 22. PMID: 39649031; PMCID: PMC11622203.","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"2545_CR295","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/JLB.3MR0121-277R","volume":"110","author":"YA Ni","year":"2021","unstructured":"Ni, Y. A., H. Chen, H. Nie, B. Zheng, and Q. Gong. 2021. HMGB1: An overview of its roles in the pathogenesis of liver disease. Journal Of Leukocyte Biology 110(5):987\u2013998. https:\/\/doi.org\/10.1002\/JLB.3MR0121-277R. Epub 2021 Mar 30. PMID: 33784425.","journal-title":"Journal Of Leukocyte Biology"},{"key":"2545_CR296","doi-asserted-by":"publisher","first-page":"1336191","DOI":"10.3389\/fonc.2024.1336191","volume":"14","author":"A Fan","year":"2024","unstructured":"Fan, A., M. Gao, X. Tang, M. Jiao, C. Wang, Y. Wei, Q. Gong, and J. Zhong. 2024. HMGB1\/RAGE axis in tumor development: unraveling its significance. Frontiers In Oncology 14:1336191. https:\/\/doi.org\/10.3389\/fonc.2024.1336191. PMID: 38529373; PMCID: PMC10962444.","journal-title":"Frontiers In Oncology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02545-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02545-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02545-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:22:11Z","timestamp":1787703731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02545-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":296,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2545"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02545-z","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study was approved by the Italian Ministry of Health. All procedures were conducted in accordance with national legislation and institutional guidelines (Authorization No. 411\/2020-PR).","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":3,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"179"}}